WO2001003578A2 - Signal classification using cross channel timing algorithm - Google Patents
Signal classification using cross channel timing algorithm Download PDFInfo
- Publication number
- WO2001003578A2 WO2001003578A2 PCT/US2000/019370 US0019370W WO0103578A2 WO 2001003578 A2 WO2001003578 A2 WO 2001003578A2 US 0019370 W US0019370 W US 0019370W WO 0103578 A2 WO0103578 A2 WO 0103578A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiac
- complex
- signal
- complexes
- model
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/363—Detecting tachycardia or bradycardia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- the subject matter relates generally to medical devices and more particularly to classification of sensed cardiac complexes.
- SVTs supraventricular tachyarrhythmias
- VTs ventricular tachyarrhythmias
- SVTs and VTs are morphologically and physiologically distinct events. VTs take many forms, including ventricular fibrillation and ventricular tachycardia. Ventricular fibrillation is a condition denoted by extremely rapid, nonsynchronous contractions of the ventricles. This condition is fatal unless the heart is returned to sinus rhythm within a few minutes.
- Ventricular tachycardia are conditions denoted by a rapid heart beat, 150 to 250 beats per minute, that has its origin in some abnormal location within the ventricular myocardium. The abnormal location is typically results from damage to the ventricular myocardium from a myocardial infarction. Ventricular tachycardia can quickly degenerate into ventricular fibrillation.
- ICDs Implantable cardioverter/defibrillators
- Morphology-based algorithms have been proposed as a way of distinguishing VT from SVT. Many of these algorithms are template matching algorithms which determine the type of tachycardia by comparing features of the electrogram in question with an efficient representation of the patient's normal sinus rhythm (NSR) electrogram.
- NSR normal sinus rhythm
- the basis of appropriate discrimination using template-matching algorithms are based on the assumption that the morphology of ventricular depolarization during VT will be dissimilar to those during NSR.
- These algorithms classify cardiac complexes based on their morphological similarity to the patient's NSR complexes using only one intracardiac electrogram channel.
- the algorithm locates a fuducial point (e.g., the peak of the complex) to align the two complexes with respect to each other.
- a fuducial point e.g., the peak of the complex
- This alignment has the side effect of positioning complexes such that they appear to be more similar then they actually are. As a result, differentiating the two complexes becomes more difficult.
- the present subject matter is directed to a system and a method for distinguishing between the occurrence of a ventricular tachycardia (VT) and a supraventricular tachycardia (SVT) during a tachycardia episode.
- VT ventricular tachycardia
- SVT supraventricular tachycardia
- the system measures voltage values from predetermined positions along sensed cardiac signals. The voltage values are then compared to voltage values measured at the same relative positions along model cardiac complexes. Using this comparison, the system is able to distinguish the underlying cause of a tachycardia episode as either being an SVT or as a VT.
- a first model cardiac complex and a second model cardiac complex are detected, or sensed, in the first cardiac signal and the second cardiac signal, respectively.
- the first and second model cardiac complexes are normal sinus rhythm (NSR) cardiac complexes sensed during normal sinus rhythm.
- the first and second model cardiac complexes are cardiac complexes which are induced by electrical pulses delivered to at least one supraventricular location of the heart.
- a predetermined alignment feature is identified.
- the predetermined alignment feature of the second cardiac complex is a repeatably identifiable portion of the second cardiac complex, such as a maximum deflection point of the second cardiac complex.
- the predetermined alignment feature is then used to define, or position, a datum at a specified interval from the predetermined alignment feature.
- the datum can be thought of as a line, or a position, from which to make voltage measurements along the first cardiac signal during the first cardiac complex.
- the datum is positioned at any location between two sensed cardiac complexes. Once the datum has been positioned relative the predetermined alignment feature, a specified interval is measured between the predetermined alignment feature and the datum.
- Two or more morphological features are then selected along the first model cardiac complex.
- a measurement interval is then measured between the datum and each of the morphological features on the first model cardiac complex.
- the voltage value of the first model cardiac complex at each of the measurement intervals is measured from the first model cardiac signal.
- the values and locations of the predetermined alignment feature, the specified interval and the measurement intervals are then recorded and stored for use in classifying cardiac complexes as either VT or SVT cardiac complexes during a tachycardia episode.
- a first cardiac complex and a second cardiac complex of a cardiac cycle are detected, or sensed, in the first cardiac signal and the second cardiac signal, respectively.
- the predetermined alignment feature is identified.
- the predetermined alignment feature is then used to define, or position, the datum at the specified interval from the predetermined alignment feature.
- a voltage value is measured at each of the two or more measurement intervals from the datum along the first cardiac signal.
- the voltage values measured from the first cardiac signal are then compared voltage values measured from model complexes. Based on the comparison, the first cardiac complex is classified as either a VT complex or a SVT complex.
- a tachycardiac episode occurs, a plurality of cardiac cycles are detected in the first cardiac signal and the second cardiac signal. A predetermined number of the first cardiac complexes are classified as either VT or SVT cardiac complexes based on the present subject matter. A ventricular tachycardia episode is then declared when a threshold number of the predetermined number of the first cardiac complexes are classified as ventricular tachycardia complexes. Alternatively, a supraventricular tachycardia episode is declared when the threshold number of the predetermined number of the first cardiac complexes are classified as supraventricular tachycardia complexes.
- the present subject matter provides for a system and method of creating a template for a morphology-based algorithm which is used to classify cardiac complexes during a tachycardia episode.
- electrical energy pulses are provided to the supraventricular region of the patient's heart.
- the resulting cardiac complexes are then sensed and used to create a template for use in a morphology-based cardiac classification algorithm for classifying, categorizing or assessing a patient's cardiac condition.
- Figure 1 shows a first cardiac signal and a second cardiac signal which include a first and a second cardiac complex, respectively;
- Figure 2 is a flow diagram of one embodiment of the present subject matter
- Figure 3 is a flow diagram of one embodiment of the present subject matter
- Figure 4 is a flow diagram of one embodiment of the present subject matter
- Figure 5 shows a first cardiac signal and a second cardiac signal according to one embodiment of the present subject matter
- Figure 6 is a flow diagram of one embodiment of the present subject matter
- Figure 7 is a flow diagram of one embodiment of the present subject matter.
- Figure 8 is a flow diagram of one embodiment of the present subject matter
- Figure 9 shows a first cardiac signal and a second cardiac signal according to one embodiment of the present subject matter
- Figure 10 is a flow diagram of one embodiment of the present subject matter
- Figure 11 shows a first cardiac signal and a second cardiac signal according to one embodiment of the present subject matter
- Figure 12 is a flow diagram of one embodiment of the present subject matter
- Figure 13 is a flow diagram of one embodiment of the present subject matter
- Figure 14 shows first cardiac signals and second cardiac signals according to one embodiment of the present subject matter
- Figure 15 is a schematic view of one embodiment of an implantable medical device with an endocardial lead and a medical device programmer
- Figure 16 is a schematic view of one embodiment of an implantable medical device with an endocardial lead and a medical device programmer;
- Figure 17 is a block diagram of an implantable medical device according to one embodiment of the present system.
- Figure 18 is a block diagram of an implantable medical device according to one embodiment of the present system.
- the present subject matter allows for a cardiac complex to be quickly and accurately classified as either being an arrhythmic cardiac complex or a non- arrhythmic cardiac complex.
- One application of the present subject matter is in classifying cardiac complexes sensed during a tachycardia episode as either ventricular tachycardia (VT) or supraventricular tachycardia (SVT) complexes. Based on the classification of the cardiac complexes, the tachycardia episode can then be classified as either a VT or an SVT event.
- the present subject matter is useful in classifying a tachycardia episode having a 1:1 atrial-to-ventricular ratio.
- the present subject matter uses cardiac signals sensed in two cardiac channels to classify cardiac complexes during a tachycardia episode.
- Using two cardiac channels allows for a more complete "view" of each cardiac complex from which to classify the cardiac complex.
- two cardiac channels useful for the present subject matter include a ventricular far- field channel and a ventricular near-field channel.
- Figure 1 shows one example of a cardiac complex as it was sensed in a far-field channel 100 and a near-field channel 110.
- the cardiac signals are plotted as a voltage of the cardiac signal (y- axis) as a function of time (x-axis).
- the cardiac complexes are sensed between defibrillation electrodes which provides a signal representative of a larger region of contracting cardiac tissue.
- the far-field channel 100 includes a QRS-complex 120 which represents a ventricular contraction of a cardiac cycle.
- the cardiac complex are sensed between a pacing electrode and a second electrode. Due to its smaller size the pacing electrode sensing a more localized region of contracting tissue than the far-field signal. Differences in cardiac signals sensed in far-field and near-field signal are then used in the present subject matter to classify cardiac complexes during the tachycardia episode.
- the relative positions of the QRS-complexes in the far-field and the near- field channels contain information about the conduction path of the cardiac action potential.
- SVT complexes use the same conduction path that cardiac complexes which initiate in the supraventricular region use, as the conduction problem in an SVT is present in the supraventricular region.
- VT complexes do not use the same conduction path as cardiac complexes which initiate in the supraventricular region, as the conduction problem is present in the ventricular region.
- SVT complexes originating in the SVT region other cardiac complexes also arise in the supraventricular region. Examples include normal sinus rhythm (NSR) complexes and cardiac complexes which are initiated by pacing pulses to the supraventricular region.
- NSR normal sinus rhythm
- the similarity in cardiac complex origin between SVT cardiac complexes and NSR cardiac complexes or paced cardiac complexes, and the dissimilarity between VT cardiac complexes and the NSR cardiac complexes or paced cardiac complexes, is used in the present subject matter to help classify a cardiac complex sensed during a tachycardiac episode as either a SVT complex or a VT complex.
- a first cardiac signal and a second cardiac signal are sensed. Both the first and second cardiac signals include cardiac complexes which represent the cardiac cycle of the heart. As a cardiac cycle occurs, a first cardiac complex for a cardiac cycle is detected in the first cardiac signal and a second cardiac complex for the cardiac cycle is detected in the second cardiac signal at 210.
- a datum is positioned relative the first and second cardiac complexes. In one embodiment, the datum is a reference point or line from which distances (or times) are measured prior to taking voltage measurements from the first and second cardiac signals.
- the datum is defined, or located, at a specified interval (e.g., an interval of time) from a predetermined alignment feature located on the second cardiac complex.
- the predetermined alignment feature is a repeatably identifiable portion of a sensed cardiac complex detected in the second cardiac signal which can be used as a reference point to align and/or coordinate the position of the first and second cardiac complexes relative the datum.
- the predetermined alignment feature is the maximum deflection point of the second cardiac signal during a cardiac complex.
- the predetermined alignment feature is a point of maximum slew.
- the predetermined alignment feature is fiducial point of the second cardiac complex.
- the predetermined alignment feature can be any repeatably identifiable portion of the second cardiac complex which will be present regardless of the arrhythmia that is occurring.
- a voltage value of the first cardiac signal is measured at each of two or more measurement intervals from the datum.
- the voltage values measured from the first cardiac signal are used to create a complex feature vector.
- the complex feature vector is then compared to a template feature vector, where in one embodiment the template feature vector represents a model cardiac complex (or complexes) of a patient's heart. Based on the comparison, the cardiac complex detected in the first and second cardiac signal is then classified as either a SVT cardiac complex or a VT cardiac complex.
- model cardiac complexes are derived from cardiac complexes sensed from the patient.
- the model cardiac complex (or complexes) is derived from cardiac complexes sensed during the patient's normal sinus rhythm (NSR).
- the model cardiac complex (or complexes) is derived from sensed "induced" cardiac complexes which are the result of a cardiac cycle initiated by electrical pulses being delivered to the supraventricular region of the heart.
- Each of the cardiac complexes to be classified are then represented by a complex feature vector.
- the complex feature vector is then compared to the template feature vector and the cardiac complex is classified based on that comparison.
- Figure 3 shows one embodiment of determining the specified interval and the template feature vector from the sensed model cardiac complexes.
- a first cardiac signal and a second cardiac signal are sensed.
- a first model cardiac complex is detected in the first cardiac signal, and a second model cardiac complex is detected in the second cardiac signal.
- the first and second model cardiac complexes are representative of a cardiac cycle.
- a predetermined alignment feature is then located relative the second model cardiac complex at 320.
- the predetermined alignment feature is positioned, or located, by an attending medical personal who is viewing an image of the second cardiac signal and the second model cardiac complex.
- the image is viewed on a medical device programmer which is in communication with an implantable medical device, such as an implantable cardiac defibrillator, which is sensing the first and second cardiac signals.
- an implantable medical device such as an implantable cardiac defibrillator
- the predetermined alignment feature is then identified and the medical device programmer is used to program the implantable medical device as to the location of the predetermined alignment feature.
- the specified interval between the predetermined alignment feature and the datum is measured.
- the datum is also positioned, or located, by the attending medical personal while viewing the image of the first and second cardiac signals.
- the specified interval is then stored.
- voltage values of the first cardiac signal during the first model cardiac complex are measured at each of the two or more measurement intervals from the datum.
- the voltage values of the first cardiac signal at each of the two or more measurement intervals from the datum are then stored.
- the first and second model cardiac complexes can either be sensed during the patient's normal sinus rhythm (NSR) or be induced cardiac complexes sensed after electrical pulses have been delivered to the supraventricular region of the heart.
- Figure 4 shows one example of determining the specified interval and the template feature vector from NSR cardiac complexes.
- a first cardiac signal and a second cardiac signal are sensed during the patient's NSR.
- first and second model cardiac complexes in this case NSR cardiac complexes, are detected in the first and second cardiac signals, respectively.
- the NSR cardiac complexes from which the specified interval and the template feature vector are derived can either be a signal NSR complex which is representative of a large number of NSR complexes sensed from the patient.
- an average or median NSR cardiac complex from two or more NSR cardiac complexes is used to determine the specified interval and the template feature vector.
- a correlation coefficient for the NSR cardiac complex is calculated and NSR cardiac complexes having a correlation coefficient of greater then 0.90 are used to create the representative NSR cardiac complex.
- the patient's NSR are sensed using catheter electrodes coupled to an implantable cardioverter/defibrillator.
- the NSR complexes are sensed on far and near field signals using intracardiac electrodes implanted within the chambers of and/or on the surface of the patient's heart.
- the sensed NSR cardiac complexes are then downloaded, or transferred, to a medical device programmer.
- the medical device programmer displays NSR complexes for review and selection by attending physicians.
- the medical device programmer can also calculate the correlation coefficient for the NSR complexes based on morphological features of the complexes and derived a median or an average NSR complex.
- the predetermined alignment feature is identified in the second NSR cardiac complex.
- the predetermined alignment feature is identified by the attending physician or medical personal based on the criteria previously discussed.
- the first and second NSR cardiac complexes are displayed on the view screen of the medical device programmer. The physician or medical personnel can then identify the predetermined alignment feature on the second NSR cardiac complex.
- the predetermined alignment feature is determined using an alignment feature extraction program executed in the medical device programmer, where the attending physician or medical personal select the desired predetermined alignment feature from a predetermined list of features the medical device programmer is capable of identifying. The program then analyzes the NSR cardiac complexes to identify the predetermined alignment feature.
- the value of the specified interval is measured between the predetermined alignment feature and the datum.
- the datum is set at a position along the first and second cardiac signals between two consecutively sensed cardiac complexes.
- the specified interval is then measured between the predetermined alignment feature and the datum and the value is then stored.
- the datum is set at a specified interval of time from the predetermined alignment feature, where the specified interval of time is selected so as to position the datum along the first and second cardiac signals between consecutively sensed cardiac complexes.
- voltage values of the first cardiac signal are measured from the first NSR cardiac complex relative the datum.
- the voltage values are measured at morpho logical features of the first NSR.
- the morphological features selected from the NSR cardiac complexes include maximum or minimum deflection points of the cardiac signal, the beginning or ending of the cardiac complex, fiducial points along the cardiac signals during the NSR cardiac complex. Other selected morphological features are also possible, where the features represent repeatably identifiable potion of the first cardiac complex. The distance between each of the selected morphology features and the datum is then measured and the value of each of the distances creates a measurement interval.
- Each of the measurement intervals is then stored for subsequent use in locating a portion of the first cardiac signal sensed during a tachycardia episode.
- a voltage measurement of the first cardiac signal is then made at each of the measurement interval.
- the voltage values measured at 430 are used to create a template feature vector (TFV).
- the TFV [t j , t 2 , t 3 , t 4 , . . . ,t n ], where the elements of the feature vector (t j - t n ) are the voltage value measured from the first cardiac signal at each of the two or more measurement intervals from the datum.
- the TFV allows the entire waveform of the first NSR cardiac complex to be represented by a series, or vector, of voltage values measured along the NSR cardiac complex.
- the amount of information needed to store the representation of the complex is greatly reduced compared to storing the entire signal for the NSR cardiac complex.
- the NSR cardiac complex is being represented by a series of values derived from a cardiac signal the computational requirements in comparing the NSR cardiac complex to a cardiac complex sensed during a tachycardia episode are also greatly reduced as compared to having to analyze the morphology of the two cardiac complexes.
- a first cardiac signal 504 is shown having a first NSR cardiac complex 508 and a second cardiac signal 512 is shown having a second NSR cardiac complex 516.
- the first cardiac signal 504 is a far-field signal and the second cardiac signal 512 is a near-field signal.
- a predetermined alignment feature is located along the second NSR cardiac complex 516 as previously discussed.
- the predetermined alignment feature is a maximum deflection point 520 of the second NSR cardiac complex 516.
- other predetermined alignment features along the second NSR cardiac complex 516 could be selected.
- a datum 524 is then positioned as previously discussed at a specified interval 528 from the predetermined alignment feature.
- At least two morphology features are selected on the first NSR cardiac complex 508.
- a plurality of morphology features are shown at 532.
- morphology features can be selected at any number of positions along the first NSR cardiac complex 508.
- a measurement interval 540 is then measured between each of the selected morphology features 532 and the datum 524.
- the measurement intervals create the template feature vector as previously described.
- each of the measurement intervals 540 is stored (e.g., the length of the measurement interval 540 are stored) so subsequent voltage measurements can be made along the first cardiac signal at, or approximately at, the same location relative the predetermined alignment feature and the datum during a tachycardiac event.
- creating a template is not limited to data derived from a patient's intrinsic NSR cardiac complexes. It is also possible to provide electrical energy pulses to the supraventricular region of the patient's heart from which the resulting induced cardiac complexes are sensed and used to create a template for use in a morphology-based cardiac classification algorithm for classifying, categorizing or assessing a patient's cardiac condition.
- Figure 6 shows an embodiment of creating a template for a morphology-based algorithm which is used to classify cardiac complexes during a tachyarrhythmia episode.
- electrical energy pulses are delivered to the supraventricular region of the heart and the resulting cardiac complexes are sensed and utilized in creating one or more templates for use in a morphology-based classification algorithm.
- cardiac complexes started by the delivery of electrical energy pulses are referred to as "induced cardiac complexes.”
- At 600 at least a first cardiac signal is sensed from the patient's heart.
- the first cardiac signal is a far-field signal as previously discussed.
- electrical pulses are delivered to a supraventricular location of the patient's heart.
- the electrical pulses are pacing level pulses delivered through a pacing electrode positioned on or within the supraventricular region of the patient's heart.
- the electrical pulses cause the patient's heart to proceed through a cardiac cycle which is detected as cardiac complexes in the first cardiac signal.
- the patient is in either NSR and/or in a non-arrhythmic cardiac state.
- the electrical pulses are delivered to the supraventricular region, such as a right atrial location adjacent or near to the SA-node.
- the electrical pulses can be delivered either at the patient's intrinsic heart rate or at a rate that is above the intrinsic cardiac rate.
- the first cardiac signal is detected as the electrical pulses are delivered to the supraventricular location.
- the detected first cardiac signal includes the model cardiac complexes, which in this case are the induced cardiac complexes.
- the detected, or sensed, induced cardiac complexes are then used to create the template or "representation" of the patient's non-arrhythmic cardiac complexes.
- creating the template or representation of the patient's non-arrhythmic cardiac complexes from the induced cardiac complexes is accomplished according to the present subject matter.
- creating the template or representation of the patient's non- arrhythmic cardiac complexes from the induced cardiac complexes is accomplished according to techniques and methods known for creating templates from non-induced cardiac complexes (e.g., cardiac complexes sensed during NSR). In many cases, these non-induced cardiac complexes are used to create "templates" which are subsequently used in classifying, categorizing or assessing sensed cardiac complexes during an arrhythmic episode.
- Figure 7 shows one embodiment of developing, or creating, a template of a classification algorithm from detected cardiac complexes from induced cardiac complexes, where the classification algorithm classifies subsequently detected cardiac complexes.
- an atrial cardiac signal is sensed from a supraventricular location, where the atrial cardiac signal includes atrial cardiac complexes.
- the atrial cardiac signal is sensed with at least one implantable electrode positioned within a supraventricular location.
- an intrinsic atrial rate is calculated from the atrial cardiac complexes.
- the intrinsic atrial rate is an average intrinsic atrial rate.
- electrical pulses are delivered to the supraventricular location of the patient's heart at a rate that is equal to or greater than the patient's intrinsic atrial rate.
- the electrical pulses are delivered to the supraventricular location at a predetermined rate which is faster than the average intrinsic atrial rate.
- the predetermined rate is set at a predetermined percentage above the average intrinsic atrial rate, where the predetermined percentage is set in a range of five (5) to fifty (50), five (5) to forty (40) or ten (10) to twenty (20), where ten (10) percent is an acceptable value.
- the electrical pulses are delivered to the supraventricular location at a predetermined target heart rate.
- the predetermined target heart rate is programmed in a range of a patient's intrinsic heart rate to one hundred sixty five (165) pulses/minute (or beats/minute), where the patient's intrinsic heart rate is in the range of forty (40) to eighty (80) beats/minute.
- the predetermined target heart rate is a programmable value in the range of forty (40) to one hundred sixty five (165), eighty (80) to one hundred sixty five (165), forty (40) to one hundred twenty (120), or eighty (80) to one hundred twenty (120) pulses/minute, where seventy (70) pulses/minute is an acceptable value.
- increasing the intrinsic heart rate by delivering electrical pulses is accomplished by ramping-up, or increasing, the heart rate at a predetermined ramp acceleration.
- the predetermined ramp acceleration is used to safely accelerate the heart rate from the intrinsic rate to the new induced heart rate (e.g., the predetermined target heart rate).
- the predetermined ramp acceleration is programed to increase successive cardiac intervals at no more than five percent of the preceding cardiac interval.
- the electrical pulses are pacing level pulses that are delivered through a pacing electrode positioned on or within the supraventricular region of the patient's heart.
- the electrical pacing pulses are programmable voltage values in the range of 0.1 to 10, 0.1 to 5, 1 to 10, or 1 to 5 volts, where 1 volt is an acceptable value.
- the first cardiac signal and the second cardiac signal are sensed from the patient's heart.
- first and second model cardiac complexes are detected in the first and second cardiac signals as the electrical pulses are delivered.
- the cardiac complexes from which the specified interval and the template feature vector are derived can either be a signal cardiac complex which is representative of a large number of the induced cardiac complexes. Alternatively, an average or median cardiac complex from two or more of the induced cardiac complexes is used to determine the specified interval and the template feature vector.
- a correlation coefficient for the cardiac complex is calculated and cardiac complexes having a correlation coefficient of greater then 0.90 are used to create the representative induced cardiac complex.
- the induced cardiac complexes are sensed using catheter electrodes coupled to an implantable cardioverter/defibrillator. In one embodiment, the induced cardiac complexes are sensed on far-field and near- field signals using intracardiac electrodes implanted within the chambers of and/or on the surface of the patient's heart. The sensed induced cardiac complexes are then downloaded, or transferred, to a medical device programmer. In one embodiment, the medical device programmer displays induced cardiac complexes for review and selection by an attending physician. The medical device programmer can also calculate the correlation coefficient for the induced cardiac complexes based on morphological features of the complexes and derived a median or an average induced cardiac complexes.
- the predetermined alignment feature is identified in the second induced cardiac complex.
- the predetermined alignment feature is identified by the attending physician or medical personal based on the criteria previously discussed.
- the first and second induced cardiac complexes are displayed on the view screen of the medical device programmer. The physician or medical personnel can then identify the predetermined alignment feature on the second induced cardiac complex.
- the predetermined alignment feature is determined using an alignment feature extraction program executed in the medical device programmer, where the attending physician or medical personal select the desired predetermined alignment feature from a predetermined list of features the medical device programmer is capable of identifying. The program then analyzes the induced cardiac complexes to identify the predetermined alignment feature.
- the value of the specified interval is measured between the predetermined alignment feature and the datum.
- the datum is set at a position along the first and second cardiac signals between two consecutively sensed cardiac complexes.
- the specified interval is then measured between the predetermined alignment feature and the datum and the value stored.
- the datum is set at a specified interval of time from the predetermined alignment feature, where the specified interval of time is selected so as to position the datum along the first and second cardiac signals between consecutively sensed cardiac complexes.
- voltage values of the first cardiac signal are measured from the first induced cardiac complex relative the datum.
- the voltage values are measured at morphological features of the first induced cardiac complex.
- the morphological features selected from the induced cardiac complexes include maximum or minimum deflection points of the cardiac signal, the beginning or ending of the cardiac complex, fiducial points along the cardiac signals during the induced cardiac complex. Other selected morphological features are also possible, where the features represent repeatably identifiable potion of the first induced cardiac complex. The distance between each of the selected morphology features and the datum is then measured and the value of each of the distances creates a measurement interval.
- each of the measurement intervals is then stored for subsequent use in locating a portion of the first cardiac signal sensed during a tachycardia episode.
- a voltage measurement of the first cardiac signal is then made of each of the measurement interval.
- the voltage values measured at 760 are used to create the template feature vector (TFV).
- the TFV [t j , t 2 , t 3 , t 4 , . . . ,t n ], where the elements of the feature vector (t j - t n ) are the voltage value measured from the first induced cardiac signal at each of the two or more measurement intervals from the datum.
- the TFV allows the entire waveform of the first induced cardiac complex to be represented by a series, or vector, of voltage values measured along the induced cardiac complex.
- the amount of information needed to store the representation of the complex is greatly reduced compared to storing the entire signal for the induced cardiac complex.
- the induced cardiac complex is being represented by a series of values derived from a cardiac signal the computational requirements in comparing the induced cardiac complex (i.e., the model cardiac complex) to a cardiac complex sensed during a tachycardia episode are also greatly reduced as compared to having to analyze the morphology of the two cardiac complexes.
- a first cardiac signal and a second cardiac signal are sensed.
- the first and second cardiac signals are analyzed to determine whether a tachycardia episode is occurring.
- a tachycardia episode is detected when a sensed ventricular rate exceeds a predetermined threshold.
- the predetermined threshold is set between 150 to 180 beats per minute.
- path 818 is taken to 820.
- a first cardiac complex and a second cardiac complex are of a sensed cardiac cycle detected in the first and second cardiac signals, respectively.
- voltage measurements are made from the cardiac signals.
- the voltage measurements are then used to create a complex feature vector (CFV) for each sensed cardiac complex.
- the CFV is then compared to the TFV to classify each of the sensed cardiac complexes as either SVT complexes or VT complexes.
- the second cardiac complex is analyzed to locate the predetermined alignment feature.
- the predetermined alignment feature of the second cardiac complex is the same feature located in the second model cardiac complex.
- the datum is defined at the specified interval from the predetermined alignment feature on the second cardiac complex.
- Figure 9 shows an example of a cardiac complex sensed during a tachycardia episode.
- the first cardiac signal and the second cardiac are shown at 900 and 904, respectively.
- the first and second cardiac signals show a first cardiac complex 908 and a second cardiac complex 912 which represent a portion of a cardiac cycle sensed during a tachycardia episode.
- the predetermined alignment feature is a maximum deflection point 918 in the second cardiac complex, which was the predetermined alignment feature used in establishing the specified interval and the TFV from the NSR cardiac complex.
- the specified interval 528 is then used to define the position of the datum 524.
- the datum is defined at a scaling percentage of the specified interval from the predetermined alignment feature.
- a reason for scaling the specified interval is that during a tachycardia episode the cardiac complexes occur more rapidly. As a result the time between subsequent cardiac complexes is shorter than during either NSR or the rate of the induced cardiac complexes.
- the specified interval may need to be reduced by the scaling percentage, where the specified interval is multiplied by the scaling percentage to give a revised specified interval.
- the measurement intervals are also scaled in the same manner as the specified interval. In one embodiment, each of the two or more measurement intervals is multiplied by the scaling percentage to give revised measurement intervals.
- the voltage value of the first cardiac signal for the first cardiac complex are then measured at each of two or more revised measurement intervals from the datum.
- the scaling percentage is a function of the sensed ventricular rate, where the scaling percentage decreases as the ventricular rate increases, where the scaling percentage is programmed at a value between 50 and 100 percent.
- voltage values of the first cardiac signal are measured at the measurement intervals relative the datum.
- the measurement intervals for each of the elements of the TFV were recorded and stored for use in analyzing a tachycardiac complex during a tachycardia episode.
- measuring the voltage values from the first cardiac complex does not rely on identifying the same morphological features used to create the measurement intervals.
- the measurement intervals are used to measure the distance, or the interval, from the datum to the points, or areas, at which voltage measurements are made from the first cardiac signal. Therefore, one advantage of the present subject matter is that morphological features on the first cardiac complex sensed during a tachycardia episode do not need to be identified prior to making voltage measurements from the first cardiac signal.
- the measurement intervals are taken as the measurement intervals 540 defined in Figure 5.
- the same measurement intervals 540 are used to measure the distance from the datum 524 at which the voltage measurements are to be made along the first cardiac signal 900.
- CFV [c l 5
- the voltage values of the first cardiac complex and the model cardiac complex are compared to determine whether the cardiac complex is an SVT cardiac complex or a VT cardiac complex.
- the comparison between the two cardiac complexes is accomplished using the CFV of the cardiac complex and the TFV of the model cardiac complex.
- One example of comparing the CFV and the TFV is to calculate a correlation coefficient, r, of the CFV and the TFV as follows:
- correcoef (TFV, CFV) is the correlation coefficient between vectors TFV and CFV.
- a value of +1.0 means that TFV and CFV are correlated.
- the correlation coefficient, r, value falls below 1.0 the cardiac complex becomes less correlated with the model cardiac complex.
- the correlation coefficient computed for the TFV and the CFV for the cardiac complex is then compared to a predetermined threshold, ⁇ . When the correlation coefficient is greater than the predetermined threshold, the cardiac complex is classified as a SVT cardiac complex at 870. When the correlation coefficient is less than or equal to the predetermined threshold, the cardiac complex is classified as a VT cardiac complex at 880.
- a plurality of cardiac cycles are sensed and classified according to the present subject matter.
- the classified cardiac complexes are then used to classify the tachycardia episode as either a ventricular tachycardia episode or a supraventricular tachycardia episode.
- An example of classifying the tachycardia episode include using an X out of Y criterion, where Y is a predetermined number of cardiac complexes (e.g., first cardiac complexes) which are sensed and classified.
- Y defines a window of consecutively sensed cardiac complexes, where the window has a predetermined number of sensed cardiac complexes and a new window occurs with each consecutive cardiac complex.
- a threshold number of the first cardiac complexes are classified as either VT or SVT complexes during a window of Y cardiac complexes the tachycardia episode is classified (or declared) as either being a ventricular tachycardia episode or a supraventricular tachycardia episode.
- Y is a programmable value in the range of 8 to 50, where 10 is an acceptable number of cardiac complexes.
- X is also a programmable value in the range of 5 to 10, where 7 is an acceptable number when the number 10 is programmed for X.
- a percentage threshold of the classified cardiac complexes is used to classify the tachycardia episode.
- a percentage of the classified cardiac complexes is calculated for the plurality of sensed cardiac cycles.
- the calculated percentage of VT complexes and SVT complexes sensed during the tachycardia episode is compared to the percentage threshold. So, a ventricular tachycardia episode is declared when the threshold percentage of the first cardiac complexes from the plurality of cardiac cycles are classified as ventricular tachycardia complexes.
- a supraventricular tachycardia episode is declared when the threshold percentage of the first cardiac complexes from the plurality of cardiac cycles are classified as supraventricular tachycardia complexes.
- the predetermined percentage threshold is a programmable value in the range of 50 to 100 percent, where a value of approximately 70 percent is an acceptable value.
- the plurality of cardiac complexes used in calculating the percentage of VT and SVT complexes is also a programmable number, where the plurality of cardiac complexes is programmed in the range of between 8 to 50, where 10 is an acceptable value.
- a first cardiac signal and a second cardiac signal of a sensed cardiac complex are sensed.
- first and second model cardiac complexes e.g., NSR cardiac complexes or induced cardiac complexes
- the first and second model cardiac complexes are then positioned in an analysis window at 1020.
- the analysis window is a defined area around a portion of the first and second cardiac signals.
- first and second cardiac signals 1100 and 1104, positioned within an analysis window 1108.
- the analysis window 1108 is positioned around a first model cardiac complex 1112 and a second model cardiac complex 1116.
- at least a portion of the analysis window 1108 is used as the datum for measuring the specified interval from the predetermined alignment feature on the second cardiac complex 1116.
- the datum is selected from any position along a first horizontal axis 1120 of the analysis window 1108.
- the datum could be selected from a vertical line 1124 positioned at the time the analysis window 1108 begins.
- the datum could be selected from a vertical line 1128 positioned at the time at which the analysis window 1108 ends.
- a predetermined alignment feature is selected, or identified, from the second model cardiac complex.
- the specified interval is measured between the predetermined alignment feature and the datum at 1030.
- the measurement interval is stored for use in classifying cardiac complexes. Voltage values of the first cardiac signal are then measured at the measurement intervals on the first model cardiac complex as previously described. At 1150, voltage values of the first cardiac signal are measured from the first model cardiac complex relative the datum as previously described. The distance between each of the selected morphology features and the datum is then measured and the value of each of the distances creates a measurement interval.
- Each of the measurement intervals is then stored for subsequent use in locating a portion of the first cardiac signal sensed during a tachycardia episode.
- a voltage measurement of the first cardiac signal is then made at each of the measurement intervals and the TFV for the model cardiac complex is created and stored for subsequent use in analyzing cardiac complexes during a tachycardiac event.
- FIG 12 there is shown one embodiment of classifying a cardiac complex according to the present subject matter.
- the encircled number 1 in Figure 10 provides a link to the encircled number 1 in Figure 12.
- a first and second cardiac complex of a sensed cardiac complex is sensed in the first and second cardiac signals, respectively, during a tachycardia episode.
- the first and second cardiac complex are positioned within an analysis window.
- the alignment feature is then located on the second cardiac complex.
- the analysis window has the same horizontal axis dimension, or length, of the analysis window used for the first and second model cardiac complex in creating the TFV.
- the analysis window is then positioned around the first and second cardiac complex so the alignment feature is located at the specified interval from the datum.
- Voltage values are then measured from the first cardiac signal at the measurement intervals at 1220.
- the voltage values for the first cardiac complex are then compared to the voltage values for the first model cardiac complex to determine whether the first cardiac complex is a VT complex or a SVT complex.
- the comparison is accomplished by creating a CFV for the cardiac complex.
- the CFV and the TFV are then compared at 1230.
- a correlation coefficient, r is calculated for the CFV and the TFV.
- the correlation coefficient computed for the TFV and the CFV for the cardiac complex is then compared to the predetermined threshold, ⁇ , at 1240. When the correlation coefficient is greater than the predetermined threshold, the cardiac complex is classified as a SVT cardiac complex at 1250. When the correlation coefficient is less than or equal to the predetermined threshold, the cardiac complex is classified as a VT cardiac complex at 1260.
- a first and second cardiac complex is sensed in the first and second cardiac signals, respectively, during a tachycardia episode.
- the first and second cardiac complex are positioned relative the first and second model cardiac complexes within an analysis window.
- the alignment feature of the second cardiac complex is located and then aligned with the alignment feature on the second model cardiac complex.
- the analysis window has the same horizontal axis dimension, or length, of the analysis window used for the first and second model cardiac complex in creating the TFV. The analysis window is then positioned around the first and second cardiac complex and the first and second model cardiac complex so the alignment feature on both the second model cardiac complex and the second cardiac complex are located at the measurement interval from the datum.
- Figure 14 shows one example of both the first and second cardiac complex and the first and second model cardiac complex aligned within an analysis window 1400.
- a first model cardiac complex 1406 and a second model cardiac complex 1412 are positioned within the analysis window 1400 with an alignment feature 1418 on the second model cardiac complex 1412 positioned at a specified interval 1424 from a datum 1428.
- a first cardiac complex 1430 and a second cardiac complex 1436 of a cardiac cycle sensed during a tachycardia episode are also positioned within the analysis window 1400.
- a predetermined alignment feature 1440 on the second cardiac complex 1436 is aligned with the predetermined alignment feature 1418 on the second model cardiac complex 1412.
- the predetermined alignment feature 1440 on the second cardiac complex 1436 is positioned at the specified interval 1424 from the datum 1428.
- Voltage values are then measured from the first cardiac signal at the measurement intervals 1450.
- the voltage value at each of the measurement intervals 1450 for the first cardiac complex are then compared to the voltage value in each of the measurement intervals 1450 for the first model cardiac complex to determine whether the first cardiac complex is a VT cardiac complex or a SVT cardiac complex.
- the comparison is accomplished by creating a CFV for the cardiac complex.
- the CFV and the TFV are then compared at 1330.
- a correlation coefficient, r is calculated for the CFV and the TFV.
- the correlation coefficient computed for the TFV and the CFV for the cardiac complex is then compared to the predetermined threshold, ⁇ , at 1340. When the correlation coefficient is greater than the predetermined threshold, the cardiac complex is classified as a SVT cardiac complex at 1350. When the correlation coefficient is less than or equal to the predetermined threshold, the cardiac complex is classified as a VT cardiac complex at 1360.
- the present subject matter can be used in an implantable cardiac defibrillator (ICD) and/or an external medical device programmer.
- ICD implantable cardiac defibrillator
- the present subject matter is compatible with ICD systems having one or more intracardiac leads having one or more electrodes which are able to sense a first and second cardiac signals.
- the present medical system can also be implemented in an external cardioverter/monitor system which includes surface electrodes and/or intracardiac leads having one or more electrodes.
- the present subject matter can also be implemented in an implantable atrial cardioverter- defibrillator, which may include numerous pacing modes known in the art.
- implantable cardiac defibrillator having a microprocessor based architecture
- implantable cardiac defibrillator or other implanted device
- the implantable cardiac defibrillator may be implemented in any logic based, custom integrated circuit architecture, if desired.
- a system such as a medical device system, which includes at least one pacing electrode and at least a first defibrillation electrode and a second defibrillation electrode.
- the system includes an implantable cardiac defibrillator 1500 electrically and physically coupled to at least one intracardiac catheter 1502.
- the intracardiac catheter 1502 includes the at least one pacing electrode and the first and second defibrillation electrodes.
- Other catheter having either the first defibrillation electrode, the second defibrillation electrode or additional defibrillation electrodes could be included in the present system.
- the intracardiac catheter 1502 shown in Figure 15 is an endocardial lead adapted to be releasably coupled to the cardiac defibrillator 1500.
- the intracardiac catheter 1502 has an elongate body with a proximal end 1508 and a distal end 1510.
- the intracardiac catheter 1502 includes a pacing electrode 1512 located at, or adjacent, the distal end 1510 of the intracardiac catheter 1502. Additional pacing electrodes can also be included on the intracardiac catheter 1502 to allow for bipolar sensing and pacing with the pacing electrode 1512. In addition, other pacing and sensing electrode configurations are also possible.
- the intracardiac catheter 1502 further includes one or more defibrillation electrodes.
- the intracardiac catheter 1502 of Figure 15 includes a first defibrillation electrode 1514 and a second defibrillation electrode 1516, where the first defibrillation electrode 1514 and the second defibrillation electrode 1516 are defibrillation coil electrodes.
- the first defibrillation electrode 1514 is spaced apart and proximal from the pacing electrode 1512
- the second defibrillation electrode 1516 is spaced apart and proximal from the first defibrillation electrode 1514.
- One example of intracardiac catheter 1502 is an Endotak catheter (CPI/Guidant, St. Paul, MN).
- FIG. 16 shows one embodiment of the implantable cardiac defibrillator 1500 having an intracardiac catheter 1502 as previously described and a second intracardiac catheter 1604.
- the second intracardiac catheter 1604 includes a supraventricular pacing electrode 1610.
- the second intracardiac catheter 1604 can further include additional pacing/sensing electrodes and/or defibrillation electrodes as are known.
- Cardiac signals such as an atrial cardiac signal
- cardiac defibrillator 1500 includes control system circuitry 1700 which is coupled to a sensing system 1702.
- the sensing system 1702 includes terminals labeled with reference numbers 1704, 1708, and 1712 for connection to electrodes coupled to the surface of the intracardiac catheter 1502.
- the pacing electrode 1512 is electrically connected to terminal 1704 and to the control system circuitry 1700 through an electrically insulated conductor provided within the elongate body of the intracardiac catheter 1502.
- the first defibrillation electrode 1514 and the second defibrillation electrode 1516 are connected to terminals 1708 and 1712, respectively, and to the control system circuitry 1700 through electrically insulated conductors provided within the elongate body of the intracardiac catheter 1502.
- the control system circuitry 1700 is encased and hermetically sealed in a housing 1716 which is suitable for implanting in a human body.
- a connector block 1720 is additionally attached to the housing 1716 of the cardiac defibrillator 1500 to allow for the physical and the electrical attachment of the intracardiac catheter 1502 and the electrodes to the cardiac defibrillator 1500 and the encased control system circuitry 1700.
- control system circuitry 1700 of the cardiac defibrillator 1500 is a programmable microprocessor-based system, with a microprocessor 1724 and a memory circuit 1726, which contains parameters for various pacing, defibrillation, and sensing modes and stores data indicative of cardiac signals received by the control system circuitry 1700.
- a transmitter circuit 1728 is additionally coupled to the control system circuitry 1700 and the memory circuit 1726 to allow the cardiac defibrillator 1500 to communicate with a medical device programmer 1730.
- the transmitter circuit 1728 and the medical device programmer 1730 use a wire loop antenna 1734 and a radio frequency telemetric link, as is known in the art, to receive and transmit signals and data to and from the programmer unit 1730 and the control system circuitry 1700.
- the second cardiac signal is a near-field signal sensed through the pacing electrode 1512.
- the pacing electrode 1512 and the first defibrillation electrode 1514 are used to sense the near-field cardiac signal or rate signal.
- the pacing electrode 1512 and first defibrillation electrode 1514 are coupled to a sense amplifier 1740 within the sensing system 1702 to allow for the second cardiac signal as previously described to be sensed.
- the connections of the present control circuit is adapted to allow for the near-field cardiac signals to be sensed between the pacing electrode 1512 and the housing 1716.
- the first cardiac signal is a far-field signal.
- the first cardiac signal is sensed between the first defibrillation electrode 1514 and the second defibrillation electrode 1516 which are coupled to the sense amplifier 1754.
- the connections of the present control circuitry is adapted to allow for the first cardiac signal can also be sensed between the first defibrillation electrode 1514, the second defibrillation electrode 1516 and the housing 1530.
- the control system 1700 monitors the first cardiac signal for a first cardiac complex and the second cardiac signal for a second cardiac complex, where the first cardiac complex and the second cardiac complex represent a cardiac cycle.
- the output of the sense amplifier 1740 is shown connected to an R-wave detector 1744 which is coupled to the control system 1700.
- the R-wave detector 1744 determines the ventricular rate from the sensed cardiac complexes.
- the ventricular rate is then supplied to the microprocessor 1724.
- the microprocessor 1724 analyzes the ventricular rate to detect when the ventricular rate exceeds a predetermined threshold. When the ventricular rate exceeds the predetermined threshold, the microprocessor 1724 declares a tachycardia episode.
- the predetermined threshold is a programmable value set between 150 to 180 beats per minute.
- the R-wave detector circuit 1744 detects the second cardiac complex in the second cardiac signal and provides the second cardiac signal to an alignment circuit 1750 coupled to the control system 1700.
- the alignment circuit 1750 analyzes the second cardiac complex to locate a predetermined alignment feature on the second cardiac complex and positions a datum at a specified interval from the alignment feature on the second cardiac complex.
- the alignment circuit 1750 also receives the first cardiac signal and detects the first cardiac complex as the cardiac cycle is sensed.
- the alignment circuit 1750 receives the first cardiac complex and the second cardiac complex of the sensed cardiac cycle and analyzes the second cardiac complex to locate the predetermined alignment feature.
- a location algorithm according to the present subject matter for identifying the alignment feature on the second cardiac complex is stored in the memory 1726 and executed in the alignment circuit 1750.
- the alignment circuit 1750 also positions the datum at the specified interval from the alignment feature on the second cardiac complex.
- the specified interval of the datum is stored in memory 1726.
- the alignment circuit 1750 positions the analysis window around the first and second cardiac complex as previously described when an analysis window is used to isolate a cardiac complex in a first and second cardiac signal.
- a morphology analyzing circuit 1754 is coupled to the alignment circuit 1750 of the control system 1700 via bus 1758.
- the morphology analyzing circuit 1754 measures the voltage value of the first cardiac signal at each of two or more measurement intervals from the datum.
- the morphology analysis circuit 1754 retrieves the measurement intervals from the memory 1726. Once the first and second cardiac complex have been aligned relative the datum, the morphology analyzing circuit 1754 measures the voltage of the first cardiac signal at each of the measurement intervals from the datum.
- a vector comparison circuit 1760 is coupled to the control system 1700, including the morphology analyzing circuit 1754, via bus 1758.
- the vector comparison circuit 1760 receives the voltage values measured at the measurement intervals and creates the complex feature vector for each of the sensed cardiac complexes. The vector comparison circuit 1760 then compares the complex feature vector to the TFV. In one embodiment, the vector comparison circuit 1760 calculates the correlation coefficient between the TFV and the CFV of each of the sensed cardiac complexes. The vector comparison circuit 1760 then compares the correlation coefficient to the predetermined threshold, ⁇ . In one embodiment, the predetermined threshold is stored in the memory 1726. The vector comparison circuit 1760 classifies the cardiac complex as a SVT cardiac complex when the correlation coefficient is greater than the predetermined threshold and classifies the cardiac complex as a VT cardiac complex when the correlation coefficient is less than or equal to the predetermined threshold.
- the sensing system 1702 detects a plurality of the cardiac cycles in the first cardiac signal and the second cardiac signal. As the plurality of first cardiac complexes are sensed, the vector comparison circuit 1760 classifies a predetermined number of the first cardiac complexes. The microprocessor 1724 receives the classification of the cardiac complexes as they are classified by the vector comparison circuit 1760. In one embodiment, the predetermined number of the first cardiac complexes is a window of X cardiac complexes, where a new window is created as each subsequent cardiac complex is analyzed and classified. When a threshold number, Y, of X of the cardiac complexes are classified as VT complexes the control system 1700 declares a VT episode.
- the ventricular arrhythmia is classified as a SVT episode.
- the microprocessor 1724 receives the classification of the cardiac complexes a percentage of the classified cardiac complexes is calculated. The calculated percentage of VT complexes and SVT complexes sensed for the plurality of cardiac cycles during the tachycardia episode is compared to the threshold number, where the threshold number is a percentage value. So, a ventricular tachycardia episode is declared when the threshold number, or percentage, of the first cardiac complexes from the plurality of cardiac cycles are classified as ventricular tachycardia complexes.
- a supraventricular tachycardia episode is declared when the threshold number of the first cardiac complexes from the plurality of cardiac cycles are classified as supraventricular tachycardia complexes.
- the threshold number is a programmable value in the range of 50 to 100 percent, where a value of approximately 70 percent is an acceptable value.
- the plurality of cardiac cycles sensed for classification and used in calculating the percentage of VT and SVT complexes is also a programmable number, where a value in the range of 8 to 50 classified complexes, where 10 is an acceptable value.
- the microprocessor once the ventricular episode has been classified, the microprocessor generates a signal which is delivered to a therapy output circuit 1770.
- the therapy output circuit 1770 generates electrical energy (e.g., cardioversion and/or defibrillation electrical energy) which is delivered between the first and second defibrillation electrodes.
- Electrical energy e.g., cardioversion and/or defibrillation electrical energy
- Power for the cardiac defibrillator 1500 is supplied by an electrochemical battery 1774 that is housed within the cardiac defibrillator 1500.
- FIG. 18 there is shown an embodiment of a block diagram of cardiac defibrillator 1500 shown in Figure 16.
- the cardiac defibrillator 1500 of Figure 18 includes all the components previously described in Figure 17.
- the sensing system 1702 of the cardiac defibrillator 1500 further includes terminal 1810 for connection to the supraventricular pacing electrode 1610 which is coupled to the surface of the second intracardiac catheter 1604.
- the connector block 1720 further includes a second socket which is adapted to receive the second intracardiac catheter 1604.
- the sensing system 1702 is used to detect an atrial cardiac signal with the supraventricular pacing electrode 1610.
- the control system 1700 monitors the atrial cardiac signal for atrial cardiac complexes and calculates an intrinsic atrial rate from the detected atrial cardiac complexes.
- the sensing system 1702 includes an atrial signal sense amplifier 1814 which receives the atrial cardiac signal.
- the signal from the atrial signal sense amplifier 1814 is delivered to a P-wave detector circuit 1820 which detects the occurrence of atrial cardiac complexes (atrial contractions) from the atrial cardiac signal.
- the P- wave detector circuit 1820 is coupled to bus 1758 which allow for the microprocessor 1724 to calculate an intrinsic atrial rate, including an average intrinsic atrial rate, from the sensed atrial cardiac complexes.
- the control system 1700 of Figure 18 further includes a pace output circuit 1824.
- the pace output circuit 1824 is coupled to the terminal 1810 to allow for electrical pulses to be delivered to the supraventricular pacing electrode at the predetermined rate, which can be either at the intrinsic atrial rate or at a rate that is faster than the average intrinsic atrial rate as previously described.
- the electrical pulses are delivered under the control of the control system 1700.
- the control system 1700 monitors the first cardiac signal for the first model cardiac complexes as electrical pulses are delivered to the supraventricular pacing electrode.
- the morphology analyzing circuit 1754 receives the detected first model cardiac complexes for the creation of a template.
- the template is a classification algorithm which is used to classify subsequently detected cardiac complexes.
- the morphology analyzing circuit creates a model cardiac complex from the first model cardiac complexes.
- the control system 1700 monitors the second cardiac signal for second model cardiac complexes as electrical pulses are delivered to the supraventricular pacing electrode.
- the R-wave detector circuit 1744 detects the second model cardiac complexes in the second cardiac signal and provides the second cardiac signal to the alignment circuit 1750.
- the alignment circuit 1750 analyzes each of the second model cardiac complexes to locate the predetermined alignment feature on each of the second model cardiac complexes.
- the alignment circuit 1750 positions the datum at the specified interval from the alignment feature on each of the second model cardiac complexes.
- the morphology analyzing circuit 1754 measures a voltage value of the first cardiac signal at each of two or more measurement intervals from the datum for each of the first model cardiac complexes. In one embodiment, once the morphology analyzing circuit 1754 has measured the voltage values of the cardiac signals the morphology analyzing circuit 1754 creates the template feature vector from the voltage value of the first cardiac signal at each of two or more measurement intervals from the datum for each of the first model cardiac complexes. In an alternative embodiment, the model cardiac complexes detected in the first and/or second cardiac complexes are downloaded to the programmer 1730. Once downloaded, the programmer 1730 is used to create the template from the model cardiac complexes. The template is then transmitted back to the control system 1700 where it is stored in memory 1726 for use in analyzing and classifying cardiac complexes sensed during a tachycardia episode.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU63488/00A AU6348800A (en) | 1999-07-14 | 2000-07-14 | Signal classification using cross channel timing algorithm |
DE60016276T DE60016276T2 (en) | 1999-07-14 | 2000-07-14 | CLASSIFICATION OF SIGNALS WITH A CRUEL CHANNEL TIMING ALGORITHM |
EP00950375A EP1241977B1 (en) | 1999-07-14 | 2000-07-14 | Signal classification using cross channel timing algorithm |
AT00950375T ATE282986T1 (en) | 1999-07-14 | 2000-07-14 | CLASSIFICATION OF SIGNALS USING A CROSS CHANNEL TIMING ALGORITHM |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/352,056 | 1999-07-14 | ||
US09/352,056 US6449503B1 (en) | 1999-07-14 | 1999-07-14 | Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001003578A2 true WO2001003578A2 (en) | 2001-01-18 |
WO2001003578A3 WO2001003578A3 (en) | 2002-07-11 |
Family
ID=23383605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/019370 WO2001003578A2 (en) | 1999-07-14 | 2000-07-14 | Signal classification using cross channel timing algorithm |
Country Status (6)
Country | Link |
---|---|
US (5) | US6449503B1 (en) |
EP (1) | EP1241977B1 (en) |
AT (1) | ATE282986T1 (en) |
AU (1) | AU6348800A (en) |
DE (1) | DE60016276T2 (en) |
WO (1) | WO2001003578A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002030501A1 (en) | 2000-10-10 | 2002-04-18 | Innovata Biomed Limited | Aerosol production using a frangible diaphragm |
EP3130285A1 (en) * | 2015-08-11 | 2017-02-15 | Biosense Webster (Israel) Ltd. | Matching and tracking time sequences of heart activation |
Families Citing this family (228)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5978707A (en) | 1997-04-30 | 1999-11-02 | Cardiac Pacemakers, Inc. | Apparatus and method for treating ventricular tachyarrhythmias |
US6266554B1 (en) | 1999-02-12 | 2001-07-24 | Cardiac Pacemakers, Inc. | System and method for classifying cardiac complexes |
US6308095B1 (en) * | 1999-02-12 | 2001-10-23 | Cardiac Pacemakers, Inc. | System and method for arrhythmia discrimination |
US6223078B1 (en) | 1999-03-12 | 2001-04-24 | Cardiac Pacemakers, Inc. | Discrimination of supraventricular tachycardia and ventricular tachycardia events |
US6312388B1 (en) | 1999-03-12 | 2001-11-06 | Cardiac Pacemakers, Inc. | Method and system for verifying the integrity of normal sinus rhythm templates |
US6449503B1 (en) | 1999-07-14 | 2002-09-10 | Cardiac Pacemakers, Inc. | Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm |
US6493579B1 (en) * | 1999-08-20 | 2002-12-10 | Cardiac Pacemakers, Inc. | System and method for detection enhancement programming |
US6400986B1 (en) * | 2000-04-10 | 2002-06-04 | Cardiac Pacemakers, Inc. | Adaptive anti-tachycardia therapy apparatus and method |
US6684100B1 (en) * | 2000-10-31 | 2004-01-27 | Cardiac Pacemakers, Inc. | Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification |
US6978177B1 (en) * | 2000-11-14 | 2005-12-20 | Cardiac Pacemakers, Inc. | Method and apparatus for using atrial discrimination algorithms to determine optimal pacing therapy and therapy timing |
US6751502B2 (en) | 2001-03-14 | 2004-06-15 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with defibrillation threshold prediction |
US7386344B2 (en) * | 2004-08-11 | 2008-06-10 | Cardiac Pacemakers, Inc. | Pacer with combined defibrillator tailored for bradycardia patients |
US6708058B2 (en) * | 2001-04-30 | 2004-03-16 | Cardiac Pacemakers, Inc. | Normal cardiac rhythm template generation system and method |
US6526313B2 (en) * | 2001-06-05 | 2003-02-25 | Cardiac Pacemakers, Inc. | System and method for classifying cardiac depolarization complexes with multi-dimensional correlation |
US7248921B2 (en) | 2003-06-02 | 2007-07-24 | Cameron Health, Inc. | Method and devices for performing cardiac waveform appraisal |
US7330757B2 (en) | 2001-11-21 | 2008-02-12 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
US7127289B2 (en) * | 2001-12-05 | 2006-10-24 | Cardiac Pacemakers, Inc. | Cardiac resynchronization system employing mechanical measurement of cardiac walls |
US6993393B2 (en) * | 2001-12-19 | 2006-01-31 | Cardiac Pacemakers, Inc. | Telemetry duty cycle management system for an implantable medical device |
US7729776B2 (en) * | 2001-12-19 | 2010-06-01 | Cardiac Pacemakers, Inc. | Implantable medical device with two or more telemetry systems |
US6909916B2 (en) * | 2001-12-20 | 2005-06-21 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia classification and electrode selection |
US6985773B2 (en) | 2002-02-07 | 2006-01-10 | Cardiac Pacemakers, Inc. | Methods and apparatuses for implantable medical device telemetry power management |
US7184818B2 (en) * | 2002-03-25 | 2007-02-27 | Cardiac Pacemakers, Inc. | Method and system for characterizing a representative cardiac beat using multiple templates |
US6889079B2 (en) | 2002-04-12 | 2005-05-03 | Cardiac Pacemakers, Inc. | Method and system for characterizing supraventricular rhythm during cardiac pacing |
US7245967B1 (en) | 2002-06-12 | 2007-07-17 | Pacesetter, Inc. | Parasympathetic nerve stimulation for termination of supraventricular arrhythmias |
US7139607B1 (en) * | 2002-06-12 | 2006-11-21 | Pacesetter, Inc. | Arrhythmia discrimination |
US7403819B1 (en) | 2002-06-12 | 2008-07-22 | Pacesetter, Inc. | Parasympathetic nerve stimulation for control of AV conduction |
US6950702B2 (en) * | 2002-07-15 | 2005-09-27 | Cardiac Pacemakers, Inc. | Use of curvature based features for beat detection |
US7085599B2 (en) * | 2002-10-23 | 2006-08-01 | Cardiac Pacemakers, Inc. | Characterization of supraventricular rhythm using collected cardiac beats |
US6980860B2 (en) * | 2002-10-31 | 2005-12-27 | Medtronic, Inc. | Detection of supraventricular tachycardia with 1:1 atrial to ventricular conduction |
US7031764B2 (en) * | 2002-11-08 | 2006-04-18 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods using multiple morphology templates for discriminating between rhythms |
US7144507B2 (en) * | 2002-12-11 | 2006-12-05 | Paul Baskis | Dry cycle anaerobic digester |
US7101339B2 (en) * | 2002-12-13 | 2006-09-05 | Cardiac Pacemakers, Inc. | Respiration signal measurement apparatus, systems, and methods |
US6949075B2 (en) * | 2002-12-27 | 2005-09-27 | Cardiac Pacemakers, Inc. | Apparatus and method for detecting lung sounds using an implanted device |
US20050080348A1 (en) | 2003-09-18 | 2005-04-14 | Stahmann Jeffrey E. | Medical event logbook system and method |
US7191004B2 (en) * | 2002-12-31 | 2007-03-13 | Cardiac Pacemakers, Inc. | Capture verification using an evoked response reference |
US7162301B2 (en) * | 2002-12-31 | 2007-01-09 | Cardiac Pacemakers, Inc. | Method and system for detecting capture with cancellation of pacing artifact |
US8192358B2 (en) * | 2003-04-22 | 2012-06-05 | Patrick Leahy | Device and method for use in surgery |
US7536224B2 (en) * | 2003-04-30 | 2009-05-19 | Medtronic, Inc. | Method for elimination of ventricular pro-arrhythmic effect caused by atrial therapy |
US7477932B2 (en) | 2003-05-28 | 2009-01-13 | Cardiac Pacemakers, Inc. | Cardiac waveform template creation, maintenance and use |
US7155290B2 (en) * | 2003-06-23 | 2006-12-26 | Cardiac Pacemakers, Inc. | Secure long-range telemetry for implantable medical device |
US7792571B2 (en) | 2003-06-27 | 2010-09-07 | Cardiac Pacemakers, Inc. | Tachyarrhythmia detection and discrimination based on curvature parameters |
US7500955B2 (en) | 2003-06-27 | 2009-03-10 | Cardiac Pacemaker, Inc. | Signal compression based on curvature parameters |
US7200440B2 (en) | 2003-07-02 | 2007-04-03 | Cardiac Pacemakers, Inc. | Cardiac cycle synchronized sampling of impedance signal |
US7678061B2 (en) * | 2003-09-18 | 2010-03-16 | Cardiac Pacemakers, Inc. | System and method for characterizing patient respiration |
US7591265B2 (en) | 2003-09-18 | 2009-09-22 | Cardiac Pacemakers, Inc. | Coordinated use of respiratory and cardiac therapies for sleep disordered breathing |
US7662101B2 (en) | 2003-09-18 | 2010-02-16 | Cardiac Pacemakers, Inc. | Therapy control based on cardiopulmonary status |
US7668591B2 (en) | 2003-09-18 | 2010-02-23 | Cardiac Pacemakers, Inc. | Automatic activation of medical processes |
US7720541B2 (en) | 2003-08-18 | 2010-05-18 | Cardiac Pacemakers, Inc. | Adaptive therapy for disordered breathing |
US7757690B2 (en) | 2003-09-18 | 2010-07-20 | Cardiac Pacemakers, Inc. | System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep |
US7887493B2 (en) | 2003-09-18 | 2011-02-15 | Cardiac Pacemakers, Inc. | Implantable device employing movement sensing for detecting sleep-related disorders |
US7469697B2 (en) | 2003-09-18 | 2008-12-30 | Cardiac Pacemakers, Inc. | Feedback system and method for sleep disordered breathing therapy |
US7787946B2 (en) | 2003-08-18 | 2010-08-31 | Cardiac Pacemakers, Inc. | Patient monitoring, diagnosis, and/or therapy systems and methods |
US8606356B2 (en) * | 2003-09-18 | 2013-12-10 | Cardiac Pacemakers, Inc. | Autonomic arousal detection system and method |
US8002553B2 (en) | 2003-08-18 | 2011-08-23 | Cardiac Pacemakers, Inc. | Sleep quality data collection and evaluation |
US7468040B2 (en) * | 2003-09-18 | 2008-12-23 | Cardiac Pacemakers, Inc. | Methods and systems for implantably monitoring external breathing therapy |
US8192376B2 (en) | 2003-08-18 | 2012-06-05 | Cardiac Pacemakers, Inc. | Sleep state classification |
US7396333B2 (en) | 2003-08-18 | 2008-07-08 | Cardiac Pacemakers, Inc. | Prediction of disordered breathing |
US7510531B2 (en) | 2003-09-18 | 2009-03-31 | Cardiac Pacemakers, Inc. | System and method for discrimination of central and obstructive disordered breathing events |
US7967756B2 (en) | 2003-09-18 | 2011-06-28 | Cardiac Pacemakers, Inc. | Respiratory therapy control based on cardiac cycle |
US8251061B2 (en) | 2003-09-18 | 2012-08-28 | Cardiac Pacemakers, Inc. | Methods and systems for control of gas therapy |
EP1512430B1 (en) * | 2003-09-02 | 2008-02-13 | Biotronik GmbH & Co. KG | Device for sleep-apnea treatment |
US7092751B2 (en) * | 2003-09-23 | 2006-08-15 | Instrumentarium Corp. | Detection of atrial arrhythmia |
US7319900B2 (en) * | 2003-12-11 | 2008-01-15 | Cardiac Pacemakers, Inc. | Cardiac response classification using multiple classification windows |
US20060247693A1 (en) | 2005-04-28 | 2006-11-02 | Yanting Dong | Non-captured intrinsic discrimination in cardiac pacing response classification |
US8521284B2 (en) | 2003-12-12 | 2013-08-27 | Cardiac Pacemakers, Inc. | Cardiac response classification using multisite sensing and pacing |
US7774064B2 (en) | 2003-12-12 | 2010-08-10 | Cardiac Pacemakers, Inc. | Cardiac response classification using retriggerable classification windows |
US7353062B2 (en) | 2003-12-24 | 2008-04-01 | Cardiac Pacemakers, Inc. | Post-shock recovery monitoring for tachyarrhythmia discrimination |
US7184815B2 (en) * | 2004-02-26 | 2007-02-27 | Cardiac Pacemakers, Inc. | System and method for selection of morphology templates |
US7299086B2 (en) * | 2004-03-05 | 2007-11-20 | Cardiac Pacemakers, Inc. | Wireless ECG in implantable devices |
WO2005099817A1 (en) | 2004-04-07 | 2005-10-27 | Cardiac Pacemakers, Inc. | Rf wake-up of implantable medical device |
US7515956B2 (en) * | 2004-05-12 | 2009-04-07 | Cardiac Pacemakers, Inc. | Template based AV/VA interval comparison for the discrimination of cardiac arrhythmias |
US7616994B2 (en) * | 2004-05-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Fast post-antitachycardia pacing redetection algorithm |
US7996083B2 (en) * | 2004-06-02 | 2011-08-09 | Cardiac Pacemakers, Inc. | Far-field sensing channel for implantable cardiac device |
US7747323B2 (en) | 2004-06-08 | 2010-06-29 | Cardiac Pacemakers, Inc. | Adaptive baroreflex stimulation therapy for disordered breathing |
US7706866B2 (en) | 2004-06-24 | 2010-04-27 | Cardiac Pacemakers, Inc. | Automatic orientation determination for ECG measurements using multiple electrodes |
US7228176B2 (en) * | 2004-07-22 | 2007-06-05 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for tachyarrhythmia discrimination or therapy decisions |
US7277756B2 (en) * | 2004-08-16 | 2007-10-02 | Cardiac Pacemakers, Inc. | Risk of death indicator |
US7228173B2 (en) * | 2004-11-23 | 2007-06-05 | Cardiac Pacemakers, Inc. | Cardiac tachyarrhythmia therapy selection based on patient response information |
US7805185B2 (en) | 2005-05-09 | 2010-09-28 | Cardiac Pacemakers, In. | Posture monitoring using cardiac activation sequences |
US7457664B2 (en) | 2005-05-09 | 2008-11-25 | Cardiac Pacemakers, Inc. | Closed loop cardiac resynchronization therapy using cardiac activation sequence information |
US7277747B2 (en) * | 2004-11-23 | 2007-10-02 | Cardiac Pacemakers, Inc. | Arrhythmia memory for tachyarrhythmia discrimination |
US7933651B2 (en) * | 2004-11-23 | 2011-04-26 | Cardiac Pacemakers, Inc. | Cardiac template generation based on patient response information |
US7890159B2 (en) | 2004-09-30 | 2011-02-15 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring and tracking |
US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
US7509170B2 (en) | 2005-05-09 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes |
US7894893B2 (en) * | 2004-09-30 | 2011-02-22 | Cardiac Pacemakers, Inc. | Arrhythmia classification and therapy selection |
US7797036B2 (en) | 2004-11-30 | 2010-09-14 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring for ischemia detection |
US7212849B2 (en) | 2004-10-28 | 2007-05-01 | Cardiac Pacemakers, Inc. | Methods and apparatuses for arrhythmia detection and classification using wireless ECG |
US7328063B2 (en) * | 2004-11-30 | 2008-02-05 | Cardiac Pacemakers, Inc. | Method and apparatus for arrhythmia classification using atrial signal mapping |
US7761162B2 (en) * | 2004-12-13 | 2010-07-20 | Cardiac Pacemakers, Inc. | Capture verification with intrinsic response discrimination |
US7930029B2 (en) * | 2004-12-15 | 2011-04-19 | Cardiac Pacemakers, Inc. | Template initialization for evoked response detection |
US8229561B2 (en) * | 2004-12-15 | 2012-07-24 | Cardiac Pacemakers, Inc. | Atrial retrograde management |
US7587240B2 (en) * | 2004-12-15 | 2009-09-08 | Cardiac Pacemakers, Inc. | Atrial capture verification |
US7908006B2 (en) * | 2004-12-15 | 2011-03-15 | Cardiac Pacemakers, Inc. | Cardiac pacing response classification using an adaptable classification interval |
US7734347B2 (en) * | 2004-12-15 | 2010-06-08 | Cardiac Pacemakers, Inc. | Cardiac pacing response classification based on waveform feature variability |
US7996072B2 (en) | 2004-12-21 | 2011-08-09 | Cardiac Pacemakers, Inc. | Positionally adaptable implantable cardiac device |
JP2006185060A (en) * | 2004-12-27 | 2006-07-13 | Fujitsu Ltd | Method for inputting password |
US7295874B2 (en) * | 2005-01-06 | 2007-11-13 | Cardiac Pacemakers, Inc. | Intermittent stress augmentation pacing for cardioprotective effect |
US7430446B2 (en) * | 2005-01-20 | 2008-09-30 | Cardiac Pacemakers, Inc. | Methods and apparatuses for cardiac arrhythmia classification using morphology stability |
US8160697B2 (en) | 2005-01-25 | 2012-04-17 | Cameron Health, Inc. | Method for adapting charge initiation for an implantable cardioverter-defibrillator |
US7680534B2 (en) | 2005-02-28 | 2010-03-16 | Cardiac Pacemakers, Inc. | Implantable cardiac device with dyspnea measurement |
US7818056B2 (en) * | 2005-03-24 | 2010-10-19 | Cardiac Pacemakers, Inc. | Blending cardiac rhythm detection processes |
US7630763B2 (en) | 2005-04-20 | 2009-12-08 | Cardiac Pacemakers, Inc. | Thoracic or intracardiac impedance detection with automatic vector selection |
US7392086B2 (en) | 2005-04-26 | 2008-06-24 | Cardiac Pacemakers, Inc. | Implantable cardiac device and method for reduced phrenic nerve stimulation |
US7574260B2 (en) | 2005-04-28 | 2009-08-11 | Cardiac Pacemakers, Inc. | Adaptive windowing for cardiac waveform discrimination |
US7337000B2 (en) * | 2005-04-28 | 2008-02-26 | Cardiac Pacemakers Inc. | Selection of cardiac signal features detected in multiple classification intervals for cardiac pacing response classification |
US7499751B2 (en) * | 2005-04-28 | 2009-03-03 | Cardiac Pacemakers, Inc. | Cardiac signal template generation using waveform clustering |
US7765004B2 (en) | 2005-04-28 | 2010-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for managing fusion and noise in cardiac pacing response classification |
US7392088B2 (en) * | 2005-04-28 | 2008-06-24 | Cardiac Pacemakers, Inc. | Capture detection for multi-chamber pacing |
US7630755B2 (en) | 2005-05-04 | 2009-12-08 | Cardiac Pacemakers Inc. | Syncope logbook and method of using same |
US8055340B2 (en) | 2005-05-05 | 2011-11-08 | Cardiac Pacemakers, Inc. | Method and device for comprehensive anti-tachyarrhythmia therapy |
US7457666B2 (en) * | 2005-05-25 | 2008-11-25 | Cardiac Pacemakers, Inc. | Retrograde atrial sensing for identifying sub-threshold atrial pacing |
US20060271121A1 (en) | 2005-05-25 | 2006-11-30 | Cardiac Pacemakers, Inc. | Closed loop impedance-based cardiac resynchronization therapy systems, devices, and methods |
US7922669B2 (en) | 2005-06-08 | 2011-04-12 | Cardiac Pacemakers, Inc. | Ischemia detection using a heart sound sensor |
US9314210B2 (en) * | 2005-06-13 | 2016-04-19 | Cardiac Pacemakers, Inc. | Method and apparatus for rate-dependent morphology-based cardiac arrhythmia classification |
US7529578B2 (en) | 2005-07-12 | 2009-05-05 | Cardiac Pacemakers, Inc. | Multi channel approach to capture verification |
US8116867B2 (en) | 2005-08-04 | 2012-02-14 | Cameron Health, Inc. | Methods and devices for tachyarrhythmia sensing and high-pass filter bypass |
US9839781B2 (en) | 2005-08-22 | 2017-12-12 | Cardiac Pacemakers, Inc. | Intracardiac impedance and its applications |
US8494618B2 (en) * | 2005-08-22 | 2013-07-23 | Cardiac Pacemakers, Inc. | Intracardiac impedance and its applications |
US7908001B2 (en) * | 2005-08-23 | 2011-03-15 | Cardiac Pacemakers, Inc. | Automatic multi-level therapy based on morphologic organization of an arrhythmia |
US8457742B2 (en) | 2005-10-14 | 2013-06-04 | Nanostim, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
US9168383B2 (en) | 2005-10-14 | 2015-10-27 | Pacesetter, Inc. | Leadless cardiac pacemaker with conducted communication |
US8046060B2 (en) * | 2005-11-14 | 2011-10-25 | Cardiac Pacemakers, Inc. | Differentiating arrhythmic events having different origins |
US20070118180A1 (en) | 2005-11-18 | 2007-05-24 | Quan Ni | Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection |
US8831725B2 (en) * | 2005-11-28 | 2014-09-09 | Medtronic, Inc. | Method and apparatus for post-processing of episodes detected by a medical device |
US7702384B2 (en) * | 2005-12-13 | 2010-04-20 | Cardiac Pacemakers, Inc. | Zoneless tachyarrhythmia detection with real-time rhythm monitoring |
US7653431B2 (en) * | 2005-12-20 | 2010-01-26 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination based on determination of rate dependency |
US8532762B2 (en) * | 2005-12-20 | 2013-09-10 | Cardiac Pacemakers, Inc. | Discriminating polymorphic and monomorphic cardiac rhythms using template generation |
US7756578B2 (en) * | 2006-02-17 | 2010-07-13 | Cardiac Pacemakers, Inc. | Rhythm discrimination of sudden onset and one-to-one tachyarrythmia |
US7761150B2 (en) * | 2006-03-29 | 2010-07-20 | Medtronic, Inc. | Method and apparatus for detecting arrhythmias in a medical device |
US7894894B2 (en) * | 2006-03-29 | 2011-02-22 | Medtronic, Inc. | Method and apparatus for detecting arrhythmias in a subcutaneous medical device |
US8805526B2 (en) * | 2006-05-03 | 2014-08-12 | Cardiac Pacemakers, Inc. | Configurable medical telemetry radio system |
US8000780B2 (en) * | 2006-06-27 | 2011-08-16 | Cardiac Pacemakers, Inc. | Detection of myocardial ischemia from the time sequence of implanted sensor measurements |
US8527048B2 (en) | 2006-06-29 | 2013-09-03 | Cardiac Pacemakers, Inc. | Local and non-local sensing for cardiac pacing |
US8170668B2 (en) | 2006-07-14 | 2012-05-01 | Cardiac Pacemakers, Inc. | Baroreflex sensitivity monitoring and trending for tachyarrhythmia detection and therapy |
US7580741B2 (en) | 2006-08-18 | 2009-08-25 | Cardiac Pacemakers, Inc. | Method and device for determination of arrhythmia rate zone thresholds using a probability function |
US7738950B2 (en) * | 2006-09-13 | 2010-06-15 | Cardiac Pacemakers, Inc. | Method and apparatus for identifying potentially misclassified arrhythmic episodes |
US8712507B2 (en) | 2006-09-14 | 2014-04-29 | Cardiac Pacemakers, Inc. | Systems and methods for arranging and labeling cardiac episodes |
US8209013B2 (en) | 2006-09-14 | 2012-06-26 | Cardiac Pacemakers, Inc. | Therapeutic electrical stimulation that avoids undesirable activation |
US7738948B2 (en) * | 2006-10-31 | 2010-06-15 | Medtronic, Inc. | Form parameter forecaster for analyzing signals distorted by noise |
US8290590B2 (en) | 2006-11-17 | 2012-10-16 | Cardiac Pacemakers, Inc. | Dynamic morphology based atrial automatic threshold |
US7801610B2 (en) * | 2006-11-17 | 2010-09-21 | Cardiac Pacemakers, Inc. | Methods and systems for management of atrial retrograde conduction and pacemaker mediated tachyarrhythmia |
US7941208B2 (en) | 2006-11-29 | 2011-05-10 | Cardiac Pacemakers, Inc. | Therapy delivery for identified tachyarrhythmia episode types |
US7765002B2 (en) | 2006-12-08 | 2010-07-27 | Cardiac Pacemakers, Inc. | Rate aberrant beat selection and template formation |
US8014863B2 (en) * | 2007-01-19 | 2011-09-06 | Cardiac Pacemakers, Inc. | Heart attack or ischemia detector |
US7873414B2 (en) * | 2007-04-17 | 2011-01-18 | Cardiac Pacemakers, Inc. | Patient characteristic based adaptive anti-tachy pacing programming |
US8442631B2 (en) * | 2007-05-08 | 2013-05-14 | Cardiac Pacemakers, Inc. | System and method for determining the origin of a sensed beat |
US8224443B2 (en) * | 2007-05-08 | 2012-07-17 | Cardiac Pacemakers, Inc. | Method for controlling pacemaker therapy |
US8265736B2 (en) | 2007-08-07 | 2012-09-11 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
US9037239B2 (en) | 2007-08-07 | 2015-05-19 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
US8494630B2 (en) | 2008-01-18 | 2013-07-23 | Cameron Health, Inc. | Data manipulation following delivery of a cardiac stimulus in an implantable cardiac stimulus device |
EP2254660A1 (en) * | 2008-01-29 | 2010-12-01 | Cardiac Pacemakers, Inc. | Configurable intermittent pacing therapy |
EP2254661B1 (en) | 2008-02-14 | 2015-10-07 | Cardiac Pacemakers, Inc. | Apparatus for phrenic stimulation detection |
CA2717442C (en) | 2008-03-07 | 2017-11-07 | Cameron Health, Inc. | Accurate cardiac event detection in an implantable cardiac stimulus device |
EP2574371B1 (en) | 2008-03-07 | 2014-06-18 | Cameron Health, Inc. | Devices for accurately classifying cardiac activity |
US8483826B2 (en) * | 2008-03-17 | 2013-07-09 | Cardiac Pacemakers, Inc. | Deactivation of intermittent pacing therapy |
EP2105843B1 (en) | 2008-03-28 | 2011-03-16 | Ela Medical | Active medical device comprising perfected means for distinguishing between tachycardia with ventricular causes and tachycardia with supraventricular causes |
US8160687B2 (en) | 2008-05-07 | 2012-04-17 | Cameron Health, Inc. | Methods and devices for accurately classifying cardiac activity |
US8676303B2 (en) | 2008-05-13 | 2014-03-18 | The Regents Of The University Of California | Methods and systems for treating heart instability |
US8301244B2 (en) * | 2008-09-04 | 2012-10-30 | Cardiac Pacemakers, Inc. | Sustaining ventricular tachycardia detection |
CN104873191A (en) | 2008-10-09 | 2015-09-02 | 加利福尼亚大学董事会 | Device and process for automatically positioning biological rhythm disorder source |
DE102008043480A1 (en) * | 2008-11-05 | 2010-05-06 | Biotronik Crm Patent Ag | Single-chamber cardiac stimulator |
US8712523B2 (en) | 2008-12-12 | 2014-04-29 | Cameron Health Inc. | Implantable defibrillator systems and methods with mitigations for saturation avoidance and accommodation |
US8527068B2 (en) | 2009-02-02 | 2013-09-03 | Nanostim, Inc. | Leadless cardiac pacemaker with secondary fixation capability |
WO2010123679A1 (en) * | 2009-04-22 | 2010-10-28 | Cardiac Pacemakers, Inc. | Dynamic selection of algorithms for arrhythmia detection |
US8239011B2 (en) * | 2009-04-29 | 2012-08-07 | Cardiac Pacemakers, Inc. | Atrial arrhythmia detection and discrimination based on intracardiac impedance |
US8452405B2 (en) * | 2009-05-05 | 2013-05-28 | Cardiac Pacemakers, Inc. | Methods and systems for mitigating the occurrence of arrhythmia during atrial pacing |
DE102009002988A1 (en) * | 2009-05-11 | 2010-11-25 | Biotronik Crm Patent Ag | Implantable P-wave dispersion detector |
WO2010147773A1 (en) | 2009-06-15 | 2010-12-23 | Cardiac Pacemakers, Inc. | Apparatus for detecting tachyarrhythmia using an adjustable duration threshold |
JP5702375B2 (en) | 2009-06-29 | 2015-04-15 | キャメロン ヘルス、 インコーポレイテッド | Adaptive confirmation of treatable arrhythmias in implantable cardiac therapy devices |
US8483808B2 (en) | 2009-09-25 | 2013-07-09 | Yanting Dong | Methods and systems for characterizing cardiac signal morphology using K-fit analysis |
US8700140B2 (en) | 2010-04-08 | 2014-04-15 | The Regents Of The University Of California | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders |
US9332915B2 (en) | 2013-03-15 | 2016-05-10 | The Regents Of The University Of California | System and method to identify sources associated with biological rhythm disorders |
US10398326B2 (en) | 2013-03-15 | 2019-09-03 | The Regents Of The University Of California | System and method of identifying sources associated with biological rhythm disorders |
US9392948B2 (en) | 2011-12-09 | 2016-07-19 | The Regents Of The University Of California | System and method of identifying sources for biological rhythms |
US10434319B2 (en) | 2009-10-09 | 2019-10-08 | The Regents Of The University Of California | System and method of identifying sources associated with biological rhythm disorders |
US8744555B2 (en) | 2009-10-27 | 2014-06-03 | Cameron Health, Inc. | Adaptive waveform appraisal in an implantable cardiac system |
US8265737B2 (en) | 2009-10-27 | 2012-09-11 | Cameron Health, Inc. | Methods and devices for identifying overdetection of cardiac signals |
US20110130666A1 (en) * | 2009-11-30 | 2011-06-02 | Yanting Dong | Enhanced reporting of pathological episodes |
US8548573B2 (en) | 2010-01-18 | 2013-10-01 | Cameron Health, Inc. | Dynamically filtered beat detection in an implantable cardiac device |
US8903490B2 (en) * | 2010-03-03 | 2014-12-02 | Cardiac Pacemakers, Inc. | Methods and systems for recognizing arrhythmias using neural stimulation |
US20110270102A1 (en) | 2010-04-28 | 2011-11-03 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8401629B2 (en) | 2010-04-28 | 2013-03-19 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8315699B2 (en) | 2010-04-28 | 2012-11-20 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8406872B2 (en) | 2010-04-28 | 2013-03-26 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8437842B2 (en) | 2010-04-28 | 2013-05-07 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8543198B2 (en) | 2010-04-28 | 2013-09-24 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8271073B2 (en) | 2010-04-28 | 2012-09-18 | Michael C. Soldner | Method and apparatus for detecting and discriminating tachycardia |
US8983585B2 (en) | 2010-04-28 | 2015-03-17 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8301235B2 (en) | 2010-04-28 | 2012-10-30 | Medtronic, Inc. | Method and apparatus for detecting and discriminating tachycardia |
US8306614B2 (en) | 2010-04-28 | 2012-11-06 | Medtronic, Inc. | Method of dual EGM sensing and heart rate estimation in implanted cardiac devices |
WO2012051237A1 (en) | 2010-10-12 | 2012-04-19 | Nanostim, Inc. | Temperature sensor for a leadless cardiac pacemaker |
US9060692B2 (en) | 2010-10-12 | 2015-06-23 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
JP2013540022A (en) | 2010-10-13 | 2013-10-31 | ナノスティム・インコーポレイテッド | Leadless cardiac pacemaker with screw anti-rotation element |
EP3090779B1 (en) | 2010-12-13 | 2017-11-08 | Pacesetter, Inc. | Pacemaker retrieval systems |
EP2651494B1 (en) | 2010-12-13 | 2017-02-15 | Pacesetter, Inc. | Delivery catheter |
EP2654889B1 (en) | 2010-12-20 | 2017-03-01 | Pacesetter, Inc. | Leadless pacemaker with radial fixation mechanism |
US8165666B1 (en) | 2011-05-02 | 2012-04-24 | Topera, Inc. | System and method for reconstructing cardiac activation information |
US9107600B2 (en) | 2011-05-02 | 2015-08-18 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
CN103718191B (en) | 2011-05-02 | 2018-02-02 | 加利福尼亚大学董事会 | The system and method for arrhythmia are targetted using shaping ablation |
US9050006B2 (en) | 2011-05-02 | 2015-06-09 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
US8521281B2 (en) | 2011-10-14 | 2013-08-27 | Medtronic, Inc. | Electrogram classification algorithm |
US9511236B2 (en) | 2011-11-04 | 2016-12-06 | Pacesetter, Inc. | Leadless cardiac pacemaker with integral battery and redundant welds |
US8521269B1 (en) | 2012-06-27 | 2013-08-27 | Medtronic, Inc. | Determining tachyarrhythmia detection parameters based on prior detected episodes |
WO2014022661A1 (en) | 2012-08-01 | 2014-02-06 | Nanostim, Inc. | Biostimulator circuit with flying cell |
US9867547B2 (en) | 2012-11-29 | 2018-01-16 | Siemens Healthcare Gmbh | System and method to calculate cardiac characteristics |
EP2967404B1 (en) | 2013-03-11 | 2019-05-22 | Cameron Health, Inc. | Device implementing dual criteria for arrhythmia detection |
US9775559B2 (en) | 2013-04-26 | 2017-10-03 | Medtronic, Inc. | Staged rhythm detection system and method |
EP3092034B1 (en) | 2014-01-10 | 2019-10-30 | Cardiac Pacemakers, Inc. | Systems for detecting cardiac arrhythmias |
US10449361B2 (en) | 2014-01-10 | 2019-10-22 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US9526908B2 (en) | 2014-04-01 | 2016-12-27 | Medtronic, Inc. | Method and apparatus for discriminating tachycardia events in a medical device |
US10376705B2 (en) | 2014-04-01 | 2019-08-13 | Medtronic, Inc. | Method and apparatus for discriminating tachycardia events in a medical device |
US9808640B2 (en) | 2014-04-10 | 2017-11-07 | Medtronic, Inc. | Method and apparatus for discriminating tachycardia events in a medical device using two sensing vectors |
US9352165B2 (en) | 2014-04-17 | 2016-05-31 | Medtronic, Inc. | Method and apparatus for verifying discriminating of tachycardia events in a medical device having dual sensing vectors |
US10278601B2 (en) | 2014-04-24 | 2019-05-07 | Medtronic, Inc. | Method and apparatus for selecting a sensing vector configuration in a medical device |
US9795312B2 (en) | 2014-04-24 | 2017-10-24 | Medtronic, Inc. | Method and apparatus for adjusting a blanking period for selecting a sensing vector configuration in a medical device |
US10244957B2 (en) | 2014-04-24 | 2019-04-02 | Medtronic, Inc. | Method and apparatus for selecting a sensing vector configuration in a medical device |
US10252067B2 (en) | 2014-04-24 | 2019-04-09 | Medtronic, Inc. | Method and apparatus for adjusting a blanking period during transitioning between operating states in a medical device |
US9610025B2 (en) | 2014-07-01 | 2017-04-04 | Medtronic, Inc. | Method and apparatus for verifying discriminating of tachycardia events in a medical device having dual sensing vectors |
US10463866B2 (en) | 2014-07-11 | 2019-11-05 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US9554714B2 (en) | 2014-08-14 | 2017-01-31 | Cameron Health Inc. | Use of detection profiles in an implantable medical device |
US9561005B2 (en) | 2015-01-23 | 2017-02-07 | Medtronic, Inc. | Method and apparatus for beat acquisition during template generation in a medical device having dual sensing vectors |
US10188867B2 (en) | 2015-01-23 | 2019-01-29 | Medtronic, Inc. | Method and apparatus for beat acquisition during template generation in a medical device having dual sensing vectors |
AU2016215606B2 (en) | 2015-02-06 | 2018-05-31 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US10220213B2 (en) | 2015-02-06 | 2019-03-05 | Cardiac Pacemakers, Inc. | Systems and methods for safe delivery of electrical stimulation therapy |
US10368769B2 (en) * | 2016-07-27 | 2019-08-06 | Medtronic, Inc. | Automatic thresholds for atrial tachyarrhythmia detection in an implantable medical device |
US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
WO2019060302A1 (en) | 2017-09-20 | 2019-03-28 | Cardiac Pacemakers, Inc. | Implantable medical device with multiple modes of operation |
Family Cites Families (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2004A (en) * | 1841-03-12 | Improvement in the manner of constructing and propelling steam-vessels | ||
US4023564A (en) | 1976-01-26 | 1977-05-17 | Spacelabs, Inc. | Arrhythmia detector |
US4336810A (en) | 1980-09-30 | 1982-06-29 | Del Mar Avionics | Method and apparatus for arrhythmia analysis of ECG recordings |
US4407288B1 (en) | 1981-02-18 | 2000-09-19 | Mieczyslaw Mirowski | Implantable heart stimulator and stimulation method |
US4452248A (en) * | 1981-10-13 | 1984-06-05 | Keller Jr J Walter | Bidirectional pacemaker |
EP0108052A4 (en) | 1982-04-23 | 1985-09-26 | Survival Technology | Ambulatory monitoring system with real time analysis and telephone transmission. |
US4583553A (en) | 1983-11-15 | 1986-04-22 | Medicomp, Inc. | Ambulatory ECG analyzer and recorder |
US4589420A (en) * | 1984-07-13 | 1986-05-20 | Spacelabs Inc. | Method and apparatus for ECG rhythm analysis |
US4721114A (en) | 1986-02-21 | 1988-01-26 | Cardiac Pacemakers, Inc. | Method of detecting P-waves in ECG recordings |
US4802491A (en) | 1986-07-30 | 1989-02-07 | Massachusetts Institute Of Technology | Method and apparatus for assessing myocardial electrical stability |
US4838278A (en) | 1987-02-26 | 1989-06-13 | Hewlett-Packard Company | Paced QRS complex classifier |
US4825869A (en) | 1987-09-28 | 1989-05-02 | Telectronics N.V. | System for automatically performing a clinical assessment of an implanted pacer based on information that is telemetrically received |
US5269301A (en) | 1987-10-06 | 1993-12-14 | Leonard Bloom | Multimode system for monitoring and treating a malfunctioning heart |
US5014698A (en) | 1987-10-06 | 1991-05-14 | Leonard Bloom | Method of and system for monitoring and treating a malfunctioning heart |
US5156148A (en) | 1987-10-06 | 1992-10-20 | Leonard Bloom | System for treating a malfunctioning heart |
US5020540A (en) | 1987-10-09 | 1991-06-04 | Biometrak Corporation | Cardiac biopotential analysis system and method |
US4924875A (en) | 1987-10-09 | 1990-05-15 | Biometrak Corporation | Cardiac biopotential analysis system and method |
US4809697A (en) | 1987-10-14 | 1989-03-07 | Siemens-Pacesetter, Inc. | Interactive programming and diagnostic system for use with implantable pacemaker |
US4989610A (en) | 1987-11-16 | 1991-02-05 | Spacelabs, Inc. | Method and system of ECG data review and analysis |
US5010888A (en) * | 1988-03-25 | 1991-04-30 | Arzco Medical Electronics, Inc. | Method and apparatus for detection of posterior ischemia |
US4947857A (en) | 1989-02-01 | 1990-08-14 | Corazonix Corporation | Method and apparatus for analyzing and interpreting electrocardiograms using spectro-temporal mapping |
US5247021A (en) | 1989-06-06 | 1993-09-21 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for preparation of a polymer having reactive terminal group |
US5014284A (en) | 1989-06-30 | 1991-05-07 | Cardiac Telecom Corporation | Discrete slope delta modulation with recovery means |
US5000189A (en) | 1989-11-15 | 1991-03-19 | Regents Of The University Of Michigan | Method and system for monitoring electrocardiographic signals and detecting a pathological cardiac arrhythmia such as ventricular tachycardia |
US5086772A (en) | 1990-07-30 | 1992-02-11 | Telectronics Pacing Systems, Inc. | Arrhythmia control system employing arrhythmia recognition algorithm |
US5271411A (en) | 1990-09-21 | 1993-12-21 | Colin Electronics Co., Ltd. | Method and apparatus for ECG signal analysis and cardiac arrhythmia detection |
US5109842A (en) | 1990-09-24 | 1992-05-05 | Siemens Pacesetter, Inc. | Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system |
US5139028A (en) | 1990-10-26 | 1992-08-18 | Telectronics Pacing Systems, Inc. | Heart rejection monitoring apparatus and method |
US5107850A (en) | 1990-11-02 | 1992-04-28 | Cardiac Pacemakers, Inc. | Method and apparatus for classifying and treating cardiac arrhythmias based on atrial and ventricular activity |
US5193550A (en) | 1990-11-30 | 1993-03-16 | Medtronic, Inc. | Method and apparatus for discriminating among normal and pathological tachyarrhythmias |
US5184615A (en) | 1991-03-08 | 1993-02-09 | Telectronics Pacing Systems, Inc. | Apparatus and method for detecting abnormal cardiac rhythms using evoked potential measurements in an arrhythmia control system |
US5240009A (en) | 1991-03-25 | 1993-08-31 | Ventritex, Inc. | Medical device with morphology discrimination |
CA2106378A1 (en) | 1991-04-05 | 1992-10-06 | Tom D. Bennett | Subcutaneous multi-electrode sensing system |
US5292348A (en) | 1991-06-14 | 1994-03-08 | Telectronics Pacing Systems, Inc. | Implantable cardioverter/defibrillator and method employing cross-phase spectrum analysis for arrhythmia detection |
US5217021A (en) | 1991-07-30 | 1993-06-08 | Telectronics Pacing Systems, Inc. | Detection of cardiac arrhythmias using correlation of a cardiac electrical signals and temporal data compression |
US5255186A (en) | 1991-08-06 | 1993-10-19 | Telectronics Pacing Systems, Inc. | Signal averaging of cardiac electrical signals using temporal data compression and scanning correlation |
US5215098A (en) | 1991-08-12 | 1993-06-01 | Telectronics Pacing Systems, Inc. | Data compression of cardiac electrical signals using scanning correlation and temporal data compression |
US5478807A (en) | 1991-08-19 | 1995-12-26 | Genentech, Inc. | Use of relaxin in the treatment of bradycardia |
US5280792A (en) | 1991-09-20 | 1994-01-25 | The University Of Sydney | Method and system for automatically classifying intracardiac electrograms |
FR2685643B1 (en) | 1991-12-31 | 1994-03-11 | Ela Medical | METHOD FOR CONTROLLING AN IMPLANTED DEFIBRILLATOR. |
US5313953A (en) | 1992-01-14 | 1994-05-24 | Incontrol, Inc. | Implantable cardiac patient monitor |
US5312445A (en) | 1992-02-03 | 1994-05-17 | Telectronics Pacing Systems, Inc. | Implantable cardiac stimulating apparatus and method employing detection of P-waves from signals sensed in the ventricle |
US5292341A (en) | 1992-03-02 | 1994-03-08 | Siemens Pacesetter, Inc. | Method and system for determining and automatically adjusting the sensor parameters of a rate-responsive pacemaker |
DE69319641T2 (en) | 1992-03-09 | 1999-02-18 | Angeion Corp | Detection of tachycardia and cardiac fibrillation |
US5330504A (en) | 1992-03-16 | 1994-07-19 | Telectronics Pacing Systems, Inc. | Cardioverting defibrillating device with off-line ECG analysis |
US5360436A (en) | 1992-04-03 | 1994-11-01 | Intermedics, Inc. | Cardiac pacing responsive to multiple activity types |
ATE197761T1 (en) | 1992-04-03 | 2000-12-15 | Micromedical Ind Ltd | ARRANGEMENT FOR MONITORING PHYSIOLOGICAL PARAMETERS |
US5273049A (en) | 1992-04-09 | 1993-12-28 | Telectronics Pacing Systems, Inc. | Detection of cardiac arrhythmias using template matching by signature analysis |
US5275621A (en) | 1992-04-13 | 1994-01-04 | Medtronic, Inc. | Method and apparatus for terminating tachycardia |
US5311874A (en) | 1992-05-18 | 1994-05-17 | Cardiac Pacemakers, Inc. | Method for tachycardia discrimination |
US5687737A (en) | 1992-10-09 | 1997-11-18 | Washington University | Computerized three-dimensional cardiac mapping with interactive visual displays |
US5423325A (en) | 1993-03-12 | 1995-06-13 | Hewlett-Packard Corporation | Methods for enhancement of HRV and late potentials measurements |
DE4310412C1 (en) * | 1993-03-31 | 1994-07-21 | Manfred Dr Zehender | Device for signal analysis of the electrical potential profile of the heart excitation |
US5421830A (en) | 1993-08-27 | 1995-06-06 | Pacesetter, Inc. | Programming system having means for recording and analyzing a patient's cardiac signal |
US5400795A (en) | 1993-10-22 | 1995-03-28 | Telectronics Pacing Systems, Inc. | Method of classifying heart rhythms by analyzing several morphology defining metrics derived for a patient's QRS complex |
US5411031A (en) | 1993-11-24 | 1995-05-02 | Incontrol, Inc. | Implantable cardiac patient monitor |
DE4405827A1 (en) | 1993-12-02 | 1995-06-08 | Max Planck Gesellschaft | ECG data compression in implanted monitor system |
US5456261A (en) | 1993-12-16 | 1995-10-10 | Marquette Electronics, Inc. | Cardiac monitoring and diagnostic system |
US5713367A (en) | 1994-01-26 | 1998-02-03 | Cambridge Heart, Inc. | Measuring and assessing cardiac electrical stability |
US5458623A (en) | 1994-03-04 | 1995-10-17 | Telectronics Pacing Systems, Inc. | Automatic atrial pacing threshold determination utilizing an external programmer and a surface electrogram |
US5447519A (en) * | 1994-03-19 | 1995-09-05 | Medtronic, Inc. | Method and apparatus for discrimination of monomorphic and polymorphic arrhythmias and for treatment thereof |
US5549654A (en) | 1994-04-15 | 1996-08-27 | Medtronic, Inc. | Interactive interpretation of event markers in body-implantable medical device |
US5622178A (en) | 1994-05-04 | 1997-04-22 | Spacelabs Medical, Inc. | System and method for dynamically displaying cardiac interval data using scatter-plots |
US5464433A (en) | 1994-06-14 | 1995-11-07 | Incontrol, Inc. | Atrial defibrillator and method providing dual reset of an interval timer |
US5542430A (en) | 1994-09-16 | 1996-08-06 | Telectronics Pacing Systems, Inc. | Apparatus and method for discriminating between cardiac rhythms on the basis of their morphology using a neural network |
US5520191A (en) | 1994-10-07 | 1996-05-28 | Ortivus Medical Ab | Myocardial ischemia and infarction analysis and monitoring method and apparatus |
ZA958608B (en) * | 1994-10-13 | 1996-07-25 | Amgen Inc | Method of treating diabetes mellitus using kgf |
US5560368A (en) | 1994-11-15 | 1996-10-01 | Berger; Ronald D. | Methodology for automated QT variability measurement |
DE4444144A1 (en) | 1994-12-12 | 1996-06-13 | Pacesetter Ab | Pacemaker with improved detection of electrical signals |
US5935082A (en) | 1995-01-26 | 1999-08-10 | Cambridge Heart, Inc. | Assessing cardiac electrical stability |
ES2179183T3 (en) | 1995-02-17 | 2003-01-16 | Boston Scient Ltd | SYSTEMS AND METHODS TO MAKE MEASUREMENTS, SEQUENTIAL IN TIME, OF BIOLOGICAL EPISODES. |
US5797849A (en) | 1995-03-28 | 1998-08-25 | Sonometrics Corporation | Method for carrying out a medical procedure using a three-dimensional tracking and imaging system |
US5609158A (en) | 1995-05-01 | 1997-03-11 | Arrhythmia Research Technology, Inc. | Apparatus and method for predicting cardiac arrhythmia by detection of micropotentials and analysis of all ECG segments and intervals |
WO1997004702A1 (en) | 1995-07-28 | 1997-02-13 | Ep Technologies, Inc. | Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue |
US5724985A (en) | 1995-08-02 | 1998-03-10 | Pacesetter, Inc. | User interface for an implantable medical device using an integrated digitizer display screen |
US5848972A (en) | 1995-09-15 | 1998-12-15 | Children's Medical Center Corporation | Method for endocardial activation mapping using a multi-electrode catheter |
US5712801A (en) | 1995-09-25 | 1998-01-27 | Pacesetter, Inc. | Method for characterizing dynamical systems |
US5645070A (en) | 1995-09-25 | 1997-07-08 | Ventritex, Inc. | Method and apparatus for determining the origins of cardiac arrhythmias morphology dynamics |
US5738105A (en) | 1995-10-24 | 1998-04-14 | Angeion Corporation | Method and apparatus for sensing R-waves using both near field and far field sensing simultaneously |
JPH09173310A (en) | 1995-11-29 | 1997-07-08 | Hewlett Packard Co <Hp> | Method and device for classifying heartbeats from ecg waveform |
US5628326A (en) | 1995-11-29 | 1997-05-13 | Hewlett-Packard Company | Calculating a heart rate from an ECG waveform by discarding a percentage of R-R intervals prior to averaging |
US5682900A (en) | 1995-11-29 | 1997-11-04 | Hewlett-Packard Company | Method and apparatus for obtaining heartbeat measurements from a ECG waveform |
US5819007A (en) | 1996-03-15 | 1998-10-06 | Siemens Medical Systems, Inc. | Feature-based expert system classifier |
US5797399A (en) | 1996-04-19 | 1998-08-25 | The Regents Of The University Of Michigan | Method and apparatus for identifying and correctly responding to abnormal heart activity |
US5857977A (en) | 1996-08-08 | 1999-01-12 | The Regents Of The University Of Michigan | Method and apparatus for separation of ventricular tachycardia from ventricular fibrillation for implantable cardioverter defibrillators |
US5713366A (en) | 1996-09-16 | 1998-02-03 | Sulzer Intermedics Inc. | Method and apparatus for dual chamber cardiac analysis |
US5778881A (en) | 1996-12-04 | 1998-07-14 | Medtronic, Inc. | Method and apparatus for discriminating P and R waves |
US5755739A (en) | 1996-12-04 | 1998-05-26 | Medtronic, Inc. | Adaptive and morphological system for discriminating P-waves and R-waves inside the human body |
US5779645A (en) | 1996-12-17 | 1998-07-14 | Pacesetter, Inc. | System and method for waveform morphology comparison |
US5817133A (en) | 1997-03-04 | 1998-10-06 | Medtronic, Inc. | Pacemaker with morphological filtering of sensed cardiac signals |
US5772604A (en) | 1997-03-14 | 1998-06-30 | Emory University | Method, system and apparatus for determining prognosis in atrial fibrillation |
US5792065A (en) | 1997-03-18 | 1998-08-11 | Marquette Medical Systems, Inc. | Method and apparatus for determining T-wave marker points during QT dispersion analysis |
US5954661A (en) | 1997-03-31 | 1999-09-21 | Thomas Jefferson University | Tissue characterization and treatment using pacing |
US5868680A (en) | 1997-09-23 | 1999-02-09 | The Regents Of The University Of California | Quantitative characterization of fibrillatory spatiotemporal organization |
US6275732B1 (en) | 1998-06-17 | 2001-08-14 | Cardiac Pacemakers, Inc. | Multiple stage morphology-based system detecting ventricular tachycardia and supraventricular tachycardia |
US6101416A (en) * | 1998-07-29 | 2000-08-08 | Pacesetter, Inc. | System and method for atrial autocapture in single-chamber pacemaker modes using far-field detection |
US6370431B1 (en) * | 1998-10-26 | 2002-04-09 | Medtronic, Inc. | Pacemaker system for preventing ventricular tachycardia |
US6266554B1 (en) * | 1999-02-12 | 2001-07-24 | Cardiac Pacemakers, Inc. | System and method for classifying cardiac complexes |
US6308095B1 (en) * | 1999-02-12 | 2001-10-23 | Cardiac Pacemakers, Inc. | System and method for arrhythmia discrimination |
US6312388B1 (en) | 1999-03-12 | 2001-11-06 | Cardiac Pacemakers, Inc. | Method and system for verifying the integrity of normal sinus rhythm templates |
US6223078B1 (en) | 1999-03-12 | 2001-04-24 | Cardiac Pacemakers, Inc. | Discrimination of supraventricular tachycardia and ventricular tachycardia events |
US7203535B1 (en) * | 1999-04-01 | 2007-04-10 | Cardiac Pacemakers, Inc. | System and method for classifying tachycardia arrhythmias having 1:1 atrial-to-ventricular rhythms |
US6449503B1 (en) * | 1999-07-14 | 2002-09-10 | Cardiac Pacemakers, Inc. | Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm |
US6671548B1 (en) | 1999-12-29 | 2003-12-30 | Pacesetter, Inc. | Implantable stimulation device and method for discrimination atrial and ventricular arrhythmias |
US6434417B1 (en) | 2000-03-28 | 2002-08-13 | Cardiac Pacemakers, Inc. | Method and system for detecting cardiac depolarization |
US6684100B1 (en) * | 2000-10-31 | 2004-01-27 | Cardiac Pacemakers, Inc. | Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification |
US6745068B2 (en) * | 2000-11-28 | 2004-06-01 | Medtronic, Inc. | Automated template generation algorithm for implantable device |
US6708058B2 (en) * | 2001-04-30 | 2004-03-16 | Cardiac Pacemakers, Inc. | Normal cardiac rhythm template generation system and method |
US6526313B2 (en) | 2001-06-05 | 2003-02-25 | Cardiac Pacemakers, Inc. | System and method for classifying cardiac depolarization complexes with multi-dimensional correlation |
US6748269B2 (en) * | 2001-10-17 | 2004-06-08 | Cardiac Pacemakers, Inc. | Algorithm for discrimination of 1:1 tachycardias |
US6760615B2 (en) * | 2001-10-31 | 2004-07-06 | Medtronic, Inc. | Method and apparatus for discriminating between tachyarrhythmias |
US6766190B2 (en) * | 2001-10-31 | 2004-07-20 | Medtronic, Inc. | Method and apparatus for developing a vectorcardiograph in an implantable medical device |
US6950696B2 (en) * | 2001-11-27 | 2005-09-27 | St. Jude Medical Ab | Method and circuit for detecting cardiac rhythm abnormalities by analyzing time differences between unipolar signals from a lead with a multi-electrode tip |
US7184818B2 (en) | 2002-03-25 | 2007-02-27 | Cardiac Pacemakers, Inc. | Method and system for characterizing a representative cardiac beat using multiple templates |
US7031764B2 (en) | 2002-11-08 | 2006-04-18 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods using multiple morphology templates for discriminating between rhythms |
US7515956B2 (en) | 2004-05-12 | 2009-04-07 | Cardiac Pacemakers, Inc. | Template based AV/VA interval comparison for the discrimination of cardiac arrhythmias |
US7653431B2 (en) * | 2005-12-20 | 2010-01-26 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination based on determination of rate dependency |
-
1999
- 1999-07-14 US US09/352,056 patent/US6449503B1/en not_active Expired - Lifetime
-
2000
- 2000-07-14 AT AT00950375T patent/ATE282986T1/en not_active IP Right Cessation
- 2000-07-14 WO PCT/US2000/019370 patent/WO2001003578A2/en active IP Right Grant
- 2000-07-14 DE DE60016276T patent/DE60016276T2/en not_active Expired - Lifetime
- 2000-07-14 AU AU63488/00A patent/AU6348800A/en not_active Abandoned
- 2000-07-14 EP EP00950375A patent/EP1241977B1/en not_active Expired - Lifetime
-
2002
- 2002-07-23 US US10/202,297 patent/US6889081B2/en not_active Expired - Lifetime
-
2005
- 2005-03-11 US US11/077,653 patent/US7580744B2/en not_active Expired - Fee Related
-
2009
- 2009-08-24 US US12/546,381 patent/US8050757B2/en not_active Expired - Fee Related
-
2011
- 2011-10-31 US US13/285,483 patent/US8315697B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
None |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002030501A1 (en) | 2000-10-10 | 2002-04-18 | Innovata Biomed Limited | Aerosol production using a frangible diaphragm |
EP3130285A1 (en) * | 2015-08-11 | 2017-02-15 | Biosense Webster (Israel) Ltd. | Matching and tracking time sequences of heart activation |
CN106419896A (en) * | 2015-08-11 | 2017-02-22 | 韦伯斯特生物官能(以色列)有限公司 | Matching and tracking time sequences of heart activation |
US10506939B2 (en) | 2015-08-11 | 2019-12-17 | Biosense Webster (Israel) Ltd. | Matching and tracking time sequences of heart activation |
CN106419896B (en) * | 2015-08-11 | 2021-01-12 | 韦伯斯特生物官能(以色列)有限公司 | Matching and tracking time series of cardiac activations |
Also Published As
Publication number | Publication date |
---|---|
US7580744B2 (en) | 2009-08-25 |
WO2001003578A3 (en) | 2002-07-11 |
ATE282986T1 (en) | 2004-12-15 |
US20090312811A1 (en) | 2009-12-17 |
US6449503B1 (en) | 2002-09-10 |
AU6348800A (en) | 2001-01-30 |
EP1241977B1 (en) | 2004-11-24 |
DE60016276T2 (en) | 2006-03-02 |
US8050757B2 (en) | 2011-11-01 |
US20030060849A1 (en) | 2003-03-27 |
US8315697B2 (en) | 2012-11-20 |
US20120046566A1 (en) | 2012-02-23 |
US6889081B2 (en) | 2005-05-03 |
DE60016276D1 (en) | 2004-12-30 |
EP1241977A2 (en) | 2002-09-25 |
US20050159781A1 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6449503B1 (en) | Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm | |
US6438410B2 (en) | System and method for a classifying cardiac complexes | |
US6959212B2 (en) | System and method for arrhythmia discrimination | |
US7184815B2 (en) | System and method for selection of morphology templates | |
US7894893B2 (en) | Arrhythmia classification and therapy selection | |
US8532762B2 (en) | Discriminating polymorphic and monomorphic cardiac rhythms using template generation | |
EP1161179B1 (en) | Verifying integrity of normal template | |
US6430435B1 (en) | Multiple state morphology-based system detecting ventricular tachycardia and supraventricular tachycardia | |
US7031764B2 (en) | Cardiac rhythm management systems and methods using multiple morphology templates for discriminating between rhythms | |
US8145301B2 (en) | Blending cardiac rhythm detection processes | |
US7826893B2 (en) | Method and apparatus for generating a template for arrhythmia detection and electrogram morphology classification | |
US7277747B2 (en) | Arrhythmia memory for tachyarrhythmia discrimination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000950375 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWP | Wipo information: published in national office |
Ref document number: 2000950375 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000950375 Country of ref document: EP |